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  i 
ABSTRACT 
 
The role of executive functioning in substance dependence and addiction has received 
increased attention in recent years; however, the findings of empirical studies are at times 
contradictory and difficult to compare at face value. To address the current state of 
fragmentation and to delineate the current body of knowledge a systematic review of 
existing studies was conducted. The synthesis of the findings from these studies confirmed 
that lower neuropsychological performance scores of executive functioning are observed 
in substance dependent populations. Furthermore, the synthesis of the components of these 
studies provided a comprehensive overview and revealed a number of critical gaps in the 
current body of knowledge. The gaps include limitations concerning specific 
demographics of the samples studied (under-representation of females, adolescents, the 
elderly, individuals with limited education, and individuals from Africa, Oceania, Asia, 
Latin America and the Caribbean), as well as the scarce number of studies investigating 
specific substances; insufficient longitudinal studies; and the fragmentation of executive 
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Chapter 1: Introduction  
1.1 Introduction 
In this chapter, I provide an overview of the main themes that are investigated in this 
dissertation and place them within a broader contextual background. The problem 
statement is presented, together with the research questions and objectives. An overview of 
the methodology used in the study is provided, the significance of the study is discussed, 
and the structure of the systematic review is outlined.  
1.2 Background 
This research study is a systematic review of existing empirical studies that report 
on performance measures of executive functioning, by means of neuropsychological 
assessment techniques, in substance dependence populations. The predefined protocol for 
the systematic review is available in Appendix A. 
Substance dependence remains a global problem and continuous efforts are 
underway by leading world organisations to reduce the detrimental effects of this 
phenomenon (United Nations Office on Drugs and Crime, 2019). Substance dependence is 
harmful to both the affected individual and society at large. For the individual, this harm 
manifests in various ways, including physiological damage, psychological distress, social 
and occupational dysfunction and overall impairment in quality of life (American 
Psychiatric Association, 2013; World Health Organization, 2019). The reported prevalence 
of other psychiatric comorbidities is also very high (Abou-Saleh & Janca, 2004; DeVito et 
al., 2016; Kingston et al., 2017). Substance dependence is also strongly related to harmful 
socioeconomic issues such as violence, crime, road accidents, lost work productivity and 
health care costs (Gowing et al., 2015; Johnson & Belfer, 1995; United Nations Office on 
Drugs and Crime, 2019; World Health Organization, 2016). The global prevalence of 
substance dependence, as reported by the United Nations Office on Drugs and Crime 
(2019) is alarming: approximately 5.5 per cent of the global population, or one in every 18 
people, have used drugs in the previous year and an estimated 35 million people suffer 
from substance dependence and require treatment (United Nations Office on Drugs and 
Crime, 2019). 
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Individuals with substance dependence are regarded as suffering from a disease 
known as addiction. This disease is chronic and characterised by neurofunctional 
impairment (American Society of Addiction Medicine, 2018; World Health Organization, 
2019). Although the main emphasis in research has been on the impairment of the reward-
circuitry, other domains, such as executive functioning, have received increasing attention 
in recent years (Verdejo-García, 2017). This is because the importance of the relationship 
between executive functioning, addiction and substance dependence has been 
demonstrated and theoretical models have been developed that describe this relationship 
(Fernández-Serrano, Pérez-García, & Verdejo-García, 2011; Goldstein & Volkow, 2011; 
Koob & Volkow, 2016; Lewis, 2018).  
Executive functioning is a theoretical construct, with a history in the fields of 
psychology and neuroscience (Goldstein, et al., 2014). This multifaceted mental faculty is 
made up of various mental sub-domains and serves as a functional system that allows the 
individual to continually and efficiently adapt to the environment by means of future-
oriented, goal-directed behaviours (Jurado & Rosselli, 2007; Lezak et al., 2012). Some of 
the sub-domains of executive functioning include decision making, working memory and 
attention (Fuster, 2017). However, depending on the level of analysis, executive 
functioning can be comprised of a multitude of sub-domains. To understand these 
constructs and their role in both health and disease, neuropsychological assessment 
instruments have been developed. These standardised instruments measure observable 
behaviour to make inferences about mental faculties that cannot be observed directly 
(Lezak et al., 2012). These measurement techniques continuously improve and new tools 
are developed with advances in science and technology. 
1.3 Problem Statement 
The findings of existing empirical studies related to executive functioning and 
substance dependence are at times contradictory and difficult to compare at face value. 
More specifically, the status of the existing body of knowledge is unclear in terms of 
potential gaps and exhaustive evidence. In addition, related research, in the form of 
existing systematic reviews, indicates that the heterogeneity of empirical studies is very 
high. Some of the main reasons include the assessment of diverse population samples, 
different substance use behaviours, the use of different assessment measures, the 
measurement of different constructs or different theoretical levels of analysis (Cohen & 
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Weinstein, 2018; Crean et al., 2011; Potvin et al., 2018; Stevens et al., 2014).  The same 
lack of clarity is evident in the field of executive functioning. Research of executive 
functioning has rapidly grown into a vast area of neuroscience with high fragmentation 
into separate niches and sub-niches, often with little interaction (Goldberg, 2017). Also, 
the numerous conceptual models or frameworks (Chan et al., 2008; Jurado & Rosselli, 
2007) with disagreement in constructs, scope and level of analysis (Goldberg, 2017; 
Goldstein et al., 2014; Miyake & Friedman, 2012) contribute to the heterogeneity in 
existing reviews. This makes evidence synthesis difficult and at times impossible. These 
ambiguities and contradictions in the literature need to be explored and delineated. 
1.4 Study Aims and Objectives 
The main objectives of the systematic review are to identify the available empirical 
studies related to substance dependence and the neuropsychological assessment of 
executive functions and, by the use of appropriate methods, to analyse and synthesise the 
evidence in order to delineate the current body of knowledge and address the current state 
of fragmentation. This is accomplished by answering the following predefined review 
questions: 
• Which substance dependent populations have been assessed using 
neuropsychological measures for executive functioning? 
• Which assessments and batteries were used to measure executive functioning? 
• What comparators were used in the respective studies? 
• What are the findings of the neuropsychological assessment measures? 
• In what settings were assessments conducted? 
• Which study designs were used? 
• What is the risk of bias within the respective studies? 
• What are the key consensus or near-consensus findings regarding the relationship 
between executive functions and substance dependence? 
• Are there any marked differences or inconsistencies between studies? 
• What are the strengths and limitations of the study designs that were used? 
• Are there any controversial issues? 
• Is exhaustive evidence provided or are there gaps and a need for further research? 
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1.5 Significance of the Study  
The systematic review methodology is considered the gold standard way to 
synthesise studies informing the same research problem or questions. Currently, no 
systematic review exists with the scope of the current study. In terms of the problems 
identified, this study aims to contribute by investigating the manner and extent to which 
impairment in executive functioning plays a role as a risk factor in substance dependence 
and addiction. Additionally, the study aims to identify contradictions in research studies 
and possible reasons for these, including theoretical fragmentation, methodological aspects 
and heterogenic factors. The results from this review may contribute to our understanding 
of substance dependence, neuropsychological assessment and executive functioning and 
the impairment of executive functioning as a risk factor in addiction. The possible gaps 
and exhaustive evidence revealed by a systematic review of the available literature may 
also guide future research. 
1.6 Overview of the Methodology  
A systematic review involves synthesising large bodies of previously conducted (and 
usually published) research and as such is typically grounded in an empirical research 
paradigm in that data is gathered and analysed in an objective manner. However, the types 
of previous research that is synthesised does not have to be limited to empirical work, but 
could, for example, include qualitative case studies, grounded theory research, and the like. 
For the current review only studies conducted within a broadly empirical frame are 
included. 
In terms of methods, a systematic review follows stages that are well-defined and 
transparent. This ensures the legitimacy of the identification of available data. It also 
ensures the accurate synthesis of the findings to provide relevant conclusions. The key 
elements of the systematic review methodology are: (1) a pre-defined protocol, (2) an 
exhaustive literature search, (3) the screening and selection of studies using specified 
inclusion and exclusion criteria, (4) data extraction of the included studies, (5) quality 
assessment, and (6) the analysis and synthesis of the extracted data (Boland et al., 2017; 
Gough et al, 2012).  
Regarding ethical considerations, these may arise where the review is, for example, 
based on confidential or embargoed previous work, but the current review is limited to 
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work that had previously been published in the academic literature, and where further 
review and scrutiny by peers are therefore implicitly invited. 
1.7 Chapter Overview 
In Chapter 2, a theoretical review is presented to provide a context for the 
systematic review. This serves as both a conceptual framework for the research study and a 
primer for the reader. The main themes that are discussed include substance dependence, 
neuropsychological assessment and executive functioning. 
Chapter 3 presents the general research approach adopted, as well as the specifics of 
how it was applied to the current study. Systematic reviews are still relatively uncommon 
in psychology and, therefore, I present the conceptual basics of systematic review 
methodology in some detail, together with a description of the techniques of applying it in 
practice. In the second part of the chapter, I describe the procedures followed in the 
systematic review with detailed explanations of each step in the process. 
The results are reported in Chapter 4 by describing how the extracted data from the 
390 studies was synthesised and presenting the subsequent findings. These findings 
include the demographics and other characteristics of the population samples; the methods 
for diagnostic and neuropsychological assessment; the general study characteristics such as 
study designs, settings and countries; and finally, the results pertaining to executive 
functioning and substance dependence. 
Chapter 5 presents a discussion of the results and of the conclusions that can be 
drawn from them. Key findings are highlighted and the strengths and limitations of the 
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Chapter 2: Literature Review  
2.1 Introduction 
In this chapter, I present a theoretical review to provide a context for the systematic 
review which follows in Chapter 3. This literature review serves as both a conceptual 
framework for the research study and a primer for the reader. The main themes that are 
reviewed are substance dependence, neuropsychological assessment and executive 
functions. 
2.2 Substance Dependence and Addiction 
2.2.1 Introduction 
Various terminologies, models and theories are used in the field of substance 
dependence and addiction. These are delineated as a precursor for the study to ensure 
ambiguity is minimised. The historical development and different aetiological theories of 
addiction and substance dependence are presented. The behavioural neuroscience of 
substance dependence is outlined by discussing the primary neurochemical effects of 
psychoactive substances, the secondary effect of progression to addiction and exploring 
contemporary models informing current addiction research. 
2.2.2 History 
The concept of addiction has a documented history dating back 12 000 years, and 
before modern medical science the prevalent view of addiction was that of a moral 
transgression. In modern science there has been an evident evolution in the concept of 
addiction in the last couple of decades and by comparing the different versions of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM) this progression becomes 
clear (Nathan et al., 2016). The first two editions of the DSM, the DSM-I of 1952 and the 
DSM-II of 1968, deemed addiction as a societally disapproved disorder that primarily 
stems from personality disorders and, therefore, could be viewed as manifestations of 
underlying primary psychopathology (Robinson & Adinoff, 2016). The physiological 
symptoms of tolerance or withdrawal were only added to the DSM-III in 1980 as criteria 
for a diagnosis of substance dependence. Additional physiological and behavioural 
symptoms were included in both the DSM-III-R in 1987 and the DSM-IV in 1994. The 
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latest version, the DSM-5, provides numerous aetiological and symptomatic descriptions 
and emphasises the activation of the brain reward system with the use of psychoactive 
substances (American Psychiatric Association, 2013). 
2.2.3 Conceptual Issues 
 West, Marsden and Hastings (2019) stress that much fragmentation remains within 
the theoretical domain of addiction. This is evident in the lack of clarity over many 
constructs and the ambiguous ways of representing and understanding phenomena within 
the theoretical scope, as well as what constitutes to fall within this scope. Furthermore, 
ambiguous terminologies are used to describe models and theories in incongruent ways. 
Terms are used without clear definitions and at other times different terms are used for the 
same construct (West, 2001). The way in which research is reported complicates 
interpretation and in some instances makes it impossible to know what was done or what 
was discovered. Attempts at evidence synthesis in this field have been laborious and 
inefficient because of this fragmentation (West et al., 2019). Therefore, it is necessary to 
clarify the meaning of the terms addiction and substance dependence as they are used in 
the current systematic review.  
The American Society of Addiction Medicine (2018, para. 1) provides a definition 
of addiction which acknowledges the condition as a disease of the brain: 
Addiction is a primary, chronic disease of brain reward, motivation, memory and 
related circuitry. Dysfunction in these circuits leads to characteristic biological, 
psychological, social and spiritual manifestations. This is reflected in an individual 
pathologically pursuing reward and/or relief by substance use and other behaviors. 
Addiction is characterized by inability to consistently abstain, impairment in 
behavioral control, craving, diminished recognition of significant problems with 
one’s behaviors and interpersonal relationships, and a dysfunctional emotional 
response. Like other chronic diseases, addiction often involves cycles of relapse 
and remission. Without treatment or engagement in recovery activities, addiction is 
progressive and can result in disability or premature death. 
From this definition, and within the context of psychoactive substances, addiction 
is fundamentally a condition that develops following the use of a psychoactive substance 
(Koob & Volkow, 2016; Lewis, 2018; Turton & Lingford-Hughes, 2016). That is, the 
psychoactive substance has a neurochemical effect on the central nervous system which 
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then results in the condition of addiction (Scofield et al., 2016). For research purposes, this 
explicit distinction is of vital importance as addiction and substance-use are not 
synonymous. To illustrate, the use of a psychoactive substance has a primary, acute effect 
on the central nervous system (Camí et al., 2003) even though addiction may not have 
developed. Conversely, an individual who suffers from addiction may be abstinent with 
physiological withdrawal symptoms which include adverse effects on the central nervous 
system (World Health Organization, 2019). When conducting research, the distinction 
between primary effects in acute or chronic use or the secondary effects of addiction as a 
neuropathology should be clarified. 
In terms of diagnostic criteria, the American Psychiatric Association (2013) uses 
the term substance-use disorder to refer to the recurrent use of one or more substances 
which causes clinically significant impairment. Severity is classified as mild, moderate or 
severe. Furthermore, the following types of substance-related disorders are distinguished: 
alcohol; cannabis; hallucinogen; inhalant; opioid; sedative, hypnotic or anxiolytic; 
stimulant; tobacco; and other/unknown. The World Health Organization (2019) uses the 
term dependence syndrome to designate a physiological, behavioural and cognitive 
phenomenon with a strong, often overpowering, recurrent desire to take a psychoactive 
substance. In line with the types identified by the American Psychiatric Association, the 
substance dependence types are listed by the World Health Organisation as follows: 
mental and behavioural disorders due to the use of alcohol; cannabinoids; hallucinogens; 
volatile solvents; opioids; sedative-hypnotics; stimulants (including caffeine); cocaine; 
tobacco; multiple drug use or other psychoactive substances. The term substance 
dependence is used in this systematic review for any form of addiction to psychoactive 
substances whether a substance-use disorder or a dependence syndrome. 
2.2.4 Theories of Substance Dependence 
There are a multitude of theories to explain the phenomenon of substance 
dependence and the underlying condition of addiction (West, 2001) and recently the 
importance of reducing fragmentation and clarifying constructs amongst these theories 
have been emphasised (West et al., 2019). The numerous theories of addiction do not fall 
within the scope of this systematic review; however, I will provide a brief outline by using 
the four main theoretical views, namely the moral, psychoanalytical, behavioural and 
biological theories. 
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The moral theory contends that addiction is the result of deficits in the ability to 
take responsibility or a lack of spiritual strength (Lewis, 2018; Marlatt et al., 1988). Even 
though this notion may seem outdated in terms of current scientific progress, organisations 
such as Alcoholics Anonymous and Narcotics Anonymous (Krentzman et al., 2010) rely 
on this view as a foundation for treatment and, typically, religious teachers or spiritual 
guides facilitate individuals to take the moral path of abstinence. The effectiveness of these 
treatment models remains controversial and a review by Kaskutas (2009) reported mixed 
results from experimental studies. In addition, a systematic review by Ferri et al. (2006, p. 
2) found that “no experimental studies unequivocally demonstrated the effectiveness of 
AA [Alcoholics Anonymous] or TSF [Twelve Step Facilitation] approaches for reducing 
alcohol dependence or problems”.  
The psychoanalytical theory is based on individual developmental differences. The 
traditional view states that substance dependence is caused by, amongst others, the 
developmental stasis at a significant stage of personality development, in other words, the 
oral phase. Contemporary psychoanalytic views include concepts such as self-soothing and 
the enactment of perverse fantasies (Hopper, 1996), addiction as an artificially induced 
drive (Bejerot, 1972) and addiction as a form of perversion (Keller, 1992). Yet another 
contemporary view explains the condition as compulsive attempts to reduce anxiety 
(known as a driving force in psychoanalytic theory) and to protect the self from 
debilitating and painful emotions (Gumbiner, 2010). The evidence for psychoanalytical 
interventions, as treatment for addiction, have generally been considered weak (Lo Coco et 
al., 2019; Vijayakrishnan & Verma, 2018). However, a recent meta-analyses reports that a 
combination of more than one form of therapy may be more effective (De Crescenzo et al., 
2018) and another review found the effect sizes observed in various longitudinal studies 
were significant, which indicates that the effects of psychotherapy may be more evident in 
long-term follow up (Vijayakrishnan & Verma, 2018). 
The behavioural perspective contends that substance dependence is persistent and 
repetitive learnt behaviour based on short-term rewards despite the long-term negative 
consequences of said behaviour (Marlatt et al., 1988). The powerful desire to continue the 
activity is within voluntary control. Because of tolerance, the frequency, duration and 
amount of activity increase over time. The individual develops a psychological and 
physiological dependence on the gratification derived from the activity which has the same 
fundamental process as any other learned behaviour (Lewis, 2017). Other related theories 
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include the loss-grief addiction model (Beechem et al., 1996), substance dependence as a 
compulsive behaviour (Koob et al., 1998), the learning models of addiction (Lewis, 2018; 
O’Brien et al., 1992), the self-administration paradigm (Jones & Comer, 2013) and 
cognitive-behavioural models (Tiffany, 1990). A systematic review investigating the 
effectiveness of cognitive behavioural therapies as treatment revealed that lowered 
substance use and other positive changes were observed (Lee & Rawson, 2008). In another 
systematic review, the use of behavioural  therapy in substance use and depression 
reported some positive effects, however the heterogeneity of the included studies was high 
(Martínez-Vispo et al., 2018). 
The biological theory explains addiction based on underlying biological factors and 
processes (West, 2001). The current systematic review is for the most part grounded in the 
biological theory as the included studies make use of neuropsychological theories and 
instruments to conduct research (see section 2.3). The levels of analysis used in biological 
models include general biochemical mechanisms (Betz et al., 2000), structural and/or 
functional systems (Scofield et al., 2016; Volkow & Fowler, 2000; Volkow et al., 2017; 
Yager et al., 2015), genetics and epigenetics (Long et al., 2015; Morozova et al., 2012; 
Pierce et al., 2018) and neuroplasticity (Gilpin & Roberto, 2012). Preclinical and clinical 
studies have demonstrated neuroplasticity (biochemical and functional brain changes) with 
repeated exposure to psychoactive substances (Sampedro-Piquero et al., 2019). This is the 
primary tenet of the brain disease model of addiction (see section 2.2.6) which explains 
substance dependence as a progressive condition characterised by neurobiological 
adaptations with the use of psychoactive substances (Koob et al., 2016).  
Research based on the disease model has been beneficial in various ways. It has 
increased our understanding of the behavioural symptoms of substance dependence – such 
as loss of control, compulsive and inflexible behaviours and negative emotional states. It 
has also played a role in the discovery of specific molecular targets and circuits (see 
section 2.2.5) which have resulted in the development of new medications for treatment 
(Kalivas & Volkow, 2011). There are various pharmaceutical interventions available for 
substance dependence treatment, with some proven more effective than others. For 
example, naltrexone and acamprosate are used for alcohol dependence. A systematic 
review investigating the effectiveness of these pharmaceutical treatments found that both 
were effective for alcohol dependence treatment and especially as adjuvant therapies 
(Carmen et al., 2004). For opioid dependence, a Cochrane review by Mattick et al. (2014) 
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was conducted to investigate the effectiveness of buprenorphine maintenance versus 
morphine maintenance or placebo. This review found that buprenorphine may reduce 
opioid use effectively compared to placebo, but only at high doses. In addition, treatment 
retention is higher than placebo for individuals on any dose of buprenorphine. However, 
treatment retention was lower for individuals using buprenorphine than methadone. In 
addition to the development of medication, research based on this model has also informed 
and improved new techniques such as transcranial magnetic stimulation (a non-invasive 
magnetic stimulation of the brain which alters neural activity), as well as provided 
clinicians with a framework to guide behavioural interventions in treatment (Volkow & 
Koob, 2015). 
2.2.5 The Neurochemical Mechanisms of Psychoactive Substances 
Neuropsychological assessment entails making inferences about neurological 
mechanisms based on behavioural observations. At the most fundamental level, 
psychoactive substances alter synaptic transmission (signals within the central nervous 
system) which results in the observed physiological and behavioural effects. As a rule of 
thumb, these substances either facilitate or inhibit synaptic transmission. Substances can 
inhibit the effects of or block a neurotransmitter, in which case the substance is an 
antagonist; whereas if a substance increases the effects or mimics a neurotransmitter it is 
an agonist. The substance can also have a mixed effect as an agonist-antagonist – for 
example, agonist at some doses; antagonist at other doses. Furthermore, the varied 
effectiveness and side effects of psychoactive substances from one person to another can 
be attributed to the differences in the number, type and location of receptors between 
individuals (Kalat, 2016). The desirable effects of psychoactive substances on the central 
nervous system are the primary reason for initial use and the different classes of 
psychoactive substances have varied mechanisms of action which explain the unique 
experiences of each (Camí et al., 2003). These different mechanisms of actions would 
therefore also be of significance for the observed behaviour of participants in research. In 
addition to the unique mechanism of action of each class of substance, activation of the 
mesolimbic dopaminergic system is central to the use of all addictive psychoactive 
substances (Lüscher, 2016). In short, dopamine is released from the ventral tegmentum to 
the nucleus accumbens which results in experiences of euphoric states or relief of distress 
and, thereby, reinforcing the behaviour (Camí et al., 2003). Curiously, the latter has not 
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been observed with benzodiazepine (Turton & Lingford-Hughes, 2016); however, this may 
be because of a lack of empirical research. 
2.2.6 Contemporary Models of Addiction  
Although there are various models to explain addiction, the brain disease model of 
addiction is internationally the primary accepted model (Lewis, 2018) and it is now widely 
accepted that addiction is a chronic, relapsing brain disease which can be explained by 
neurofunctional impairments (American Psychiatric Association, 2013; American Society 
of Addiction Medicine, 2018; National Institute of Drug Abuse, 2014). The brain disease 
model has nonetheless been challenged within the addiction field (Gruenert, 2010; Kalant, 
2010; Satel & Lilienfeld, 2013) with the biggest alternative contender being the 
developmental learning model (Lewis, 2017, 2018).  
Volkow et al. (2016) present the brain disease model of addiction and explain the 
phenomenon as progressive neuroadaptations with reoccurring stages that present with 
specific behavioural and clinical characteristics. These stages are (1) binge and 
intoxication, (2) withdrawal and negative affect and (3) preoccupation and anticipation. As 
the respective stages reoccur, neuroadaptations are reinforced, and the severity of the 
addictive process increases, hence the progressive nature of the condition. These 
progressive neuroadaptations which manifest from initial experimental use to the transition 
to addiction can be explained by changes in biochemistry (Camí et al., 2003; Koob & 
Simon, 2009; Turton & Lingford-Hughes, 2016), genetics (Demers et al., 2014; Volkow & 
Muenke, 2012) and functional neurocircuitry (Berridge & Robinson, 2016; Everitt & 
Robbins, 2013; Goldstein & Volkow, 2002). During the binge and intoxication stage, 
reward regions in the brain are activated by means of a high release of dopamine. 
Subsequently, this triggers associative learning and the reward is paired with the 
environmental stimuli preceding this reward (Wise, 2008). With repeated exposure to the 
reward, dopamine is released in an anticipatory response to the environmental stimuli, in 
other words, the cues (Schultz, 2002). With manifested addiction, the reward and 
motivational systems adapt through associative learning to focus more on the potent 
release of dopamine when the reward and cues are present – withdrawal and negative 
affect, the second stage, is experienced until satiation is achieved (Berridge & Robinson, 
2016). Another important feature of this stage is that normal day-to-day conditions lose 
motivational weight. In other words, any activities or situations that provided pleasure to 
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the individual before are no longer pleasurable and progressively social, familial, and 
occupational domains are affected. Even more, continued exposure gradually lowers the 
sensitivity of the reward system to stimulation from the new reward and results in a 
desensitization of both substance-related and non-substance-related rewards gradually 
develops (Hägele et al., 2015). In conjunction, withdrawal sensations and the associated 
negative affect intensify gradually with these progressive neuroadaptations (Koob et al., 
2016). Finally, within the preoccupation and anticipation stage, prefrontal brain regions 
and associated circuits are compromised with the continuous down-regulation of dopamine 
signalling. Self-regulation, decision making, flexibility in the selection and initiation of 
action, attribution of salience and monitoring of error are affected (Goldstein & Volkow, 
2011) and results in behavioural impairments. These are all constructs of executive 
functioning, further supporting the relevance of the current systematic review. 
The opposing developmental learning model acknowledges the neuroadaptations of 
the brain disease model but strongly rejects the ethos of the brain disease model and places 
emphasis on addiction as learned and habitual behavioural patterns. (Hall et al., 2017; 
Lewis, 2017). In short, the repetition of experiences modifies synaptic networks. This, in 
turn, creates a feedback cycle between experiences and brain changes. The brain changes 
that result from repeated learning experiences naturally settle into neural and cognitive 
habits (Lewis, 2018). Furthermore, the experiences that are repeated most often are those 
that are most compelling. Intense, recurrent desires change the speed and depth of learning 
by augmenting the reciprocal cycle between experiences and changes in synaptic 
networks. In sum, the developmental learning model emphasises that addiction is an 
outcome of natural learning which is accelerated and strengthened by the recurrent pursuit 
of attractive goals (Lewis, 2017, 2018). The latter refers to executive functioning and once 
again supports the importance of the current systematic review. Even though the two 
models disagree on the definition of addiction, both models agree on the various 
aetiological factors contributing to the development of addiction and the consequent 
neuroadaptations on various levels of analysis.  
2.3 Neuropsychological Assessment 
2.3.1 Introduction 
In this section, neuropsychological assessment as a subfield of psychometry is 
discussed. Important psychometric properties of assessment are described, which include 
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the different reliability and validity types, the conventional procedures to conduct 
assessment and the importance of cultural sensitivity. Lastly, the domains of interest for 
neuropsychological assessment are presented using an integrative conceptual framework. 
2.3.2 Definition and Overview of Neuropsychological Assessment 
Lezak et al. (2012) define neuropsychological assessment as the quantitative, 
standardised measurement of the most complex aspects of human behaviour – the mental 
faculties of cognition, executive functions and emotional processing. As with any 
psychological assessment practice, specific domains of functioning are sampled by 
neuropsychological assessment instruments and, from these, inferences can be made about 
normal and atypical functioning (Harvey, 2012; Lezak et al., 2012; Morgan & Ricker, 
2017; Schoenberg & Scott, 2011). 
The practice of psychological assessment, in general, has several characteristics 
and these are also central to the subfield of neuropsychological assessment. As outlined by 
Foxcroft and Roodt (2013), many different procedures are used in various contexts and for 
different populations. These factors determine both the appropriate selection of assessment 
instruments, the administration of the measure, and the interpretation of the obtained 
results. Administering the instruments takes place under controlled conditions and 
systematic methods are used to evaluate assessment protocols. Thereafter, specific 
guidelines are used to interpret the results of assessment and scores can either be compared 
to that of an appropriate norm group or to a predefined criterion. Scores can also be used 
for qualitative classification purposes such as personality traits or diagnostic categories. 
Furthermore, instruments are developed in a specific context and for a specific purpose 
and this should always be borne in mind when interpreting scores. Specifically, the 
normative information that is used for interpretation is limited to the characteristics of the 
normative sample. It is important that assessment instruments are supported by evidence of 
reliability and validity for the intended purpose of use. This evidence is typically available 
in a technical test manual based on appropriate theory and research, but is also 
supplemented by findings from empirical studies that were conducted after publication of 
the instrument. 
 Reliability refers to the consistency of measurement and varies with sample 
characteristics (Heale & Twycross, 2015). Ideally, reliability coefficients are determined 
by gathering data from both healthy individuals and clinical populations (Morgan & 
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Ricker, 2017). There are different types of reliability evidence to consider for 
neuropsychological assessment scores. Internal reliability reflects the degree to which 
single items within an instrument measure the same construct. To illustrate, if the internal 
reliability coefficient of the Wechsler Adult Intelligence Scale – Fourth Edition (WAIS-
IV) working memory index is r = 0.94, the working memory score obtained from 
administration of this measure has a high reliability in terms of the items within the 
measure that all measure working memory (Sherman et al., 2011). Test-retest reliability 
provides the correlation between scores of the same instrument administered on two 
different occasions. It is also called a coefficient of stability. A high test-retest reliability 
coefficient indicates that the score will show little change over time. The test-retest 
coefficient is influenced by the time interval between two administrations. There is no 
standard for this interval and it can vary from one instrument to another. When an 
instrument needs to be administered more than once, however, the confounding effects of 
practice need to be considered (Sherman et al., 2011). Alternate forms are administered to 
account for this, and the correlation between the different forms is called the coefficient of 
equivalence. However, with alternate forms, it is possible to introduce content sampling 
error and time sampling error. Instruments with alternate forms require rigorous 
psychometric standards to avoid introducing these sources of error. This includes very high 
correlations between forms, and very high test-retest reliability for both forms with 
equivalence in terms of mean scores and consistency in score classification. Many 
instruments are administered and scored in a straightforward right or wrong manner 
(Sherman et al., 2011). However, there are tests that have a subjective component with the 
potential for scorer variance. Interrater reliability refers to the degree of consensus 
between different scorers of assessment instruments. Test manuals provide specific and 
detailed instructions for the administration and scoring of instruments to avoid introducing 
errors based on scorer differences (Heale & Twycross, 2015). Assessment scores can be 
interpreted as possessing different types and degrees of reliability. How a test score is 
used, the purpose and with whom determine the importance of consideration of the 
different types of reliability (Lezak et al., 2012; Strauss, et al., 2006). For example, the 
scores obtained from a demanding decision-making assessment may have high reliability 
in normal-functioning individuals but have low reliability in individuals with physiological 
withdrawal.  
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Validity refers to what construct an instrument measures and to what degree it 
measures this construct (Heale & Twycross, 2015). Validity is related to scores in terms of 
the purpose of the instrument. Content-related validity, construct-related validity and 
criterion-related validity are the three validity types described by Strauss et al. (2006). 
Content-related validity involves whether or not the content of the assessment instrument 
covers a representative sample of the domain to be measured. This is typically determined 
by evaluating if an adequate description of the theoretical model is provided; a review of 
the literature is available; a definition of the domain of interest is provided together with a 
operationalisation of the definition (a thorough and systematic review of the domain); and 
the collection of a sample of items (adequately large to be representative of the domain 
with a sufficient range of difficulty) (Sherman et al., 2011). Construct-related validity is 
the extent to which the assessment instrument measures the intended theoretical constructs. 
Some of the factors to critically evaluate the construct-related validity of 
neuropsychological instruments include whether the constructs are formally defined; a 
measurement hypothesis is provided; the constructs have been validated through empirical 
evidence; the sensitivity of the instrument has been demonstrated; results have been 
correlated with other instruments; studies of group differences have been conducted; factor 
analytical studies have been conducted; and the level of internal consistency (Heale & 
Twycross, 2015). Criterion-related validity is the correlation coefficient between a 
criterion and predictors. This includes concurrent validity which is the accuracy of 
identification or diagnosis of current behaviour or status and predictive validity which is 
the accuracy of predicting future behaviour or category status (Sherman et al., 2011). 
Some of the factors to critically evaluate the criterion-related validity of 
neuropsychological instruments are the appropriate identification of the criterion; the 
appropriate identification of the sample group which reflects the population of interest; and 
the analysis of instrument-criterion relationships which include using contrasting groups, 
correlations with other instruments, accuracy statistics of positive predictive power, 
outcome studies and meta-analysis (Strauss et al., 2006).  
Neuropsychological assessment typically follows a sequential process of 
instrument selection, administration and the interpretation of results. In terms of instrument 
selection, a multitude of neuropsychological instruments and batteries are available for use 
(Strauss et al., 2006) and adequately framed questions must be formulated to inform 
instrument selection. The technical aspects of the instrument, as outlined in the test 
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manual, should be scrutinized to determine if the instrument will be reliable and valid for 
the intended purpose (Lezak et al., 2012). The administration of an instrument is 
standardised and done in a controlled setting. The test manual provides the required 
protocols to follow and the assessor is responsible to ensure these protocols are adhered to. 
If administration is not done as prescribed the obtained score cannot be used for 
interpretation (Strauss et al., 2006). Finally, the interpretation of results can be done in 
various ways as described by Foxcroft and Roodt (2013). Descriptive interpretation refers 
to functioning as is at the time of administration, based on currently available information. 
This form of interpretation is only valid if the conditions of construct, content and 
concurrent validity are met. Causal interpretation describes the effects of specific 
conditions or events on functioning based on assessment results. A descriptive 
interpretation will precede a causal interpretation and information from empirical 
evidence, such as studies with standardised samples, can be used to determine validity. 
Confounding variables and task impurity are important factors to consider with causal 
interpretations. Predictive interpretation relies on the relation between current functioning, 
as determined by assessment results, and a future criterion. This form of interpretation is 
subject to the predictive validity of the instrument. Lastly, evaluative interpretation is a 
combination of the interpretation of the assessment results with a value judgement. In 
applied contexts such as counselling and treatment settings evaluative interpretations are 
often used and recommendations are made which can only be justified by validity data 
(Foxcroft & Roodt, 2013). 
Various populations, contexts and assessment instruments are included the current 
systematic review. Therefore, the reliability, validity and neuropsychological assessment 
procedures are important considerations for the quality assessment of the included studies. 
2.3.3 Cultural Sensitivity 
The current systematic review is predicted to include studies from numerous 
international countries and cultures. Therefore, another important consideration for 
neuropsychological assessment is cultural sensitivity. The differences or similarities 
observed in test scores of performance between individuals from different cultural or 
language groups need to be valid. Therefore, it is important for assessment instruments to 
be equivalent in terms of the individuals having the same or similar standing on the 
measured constructs (Foxcroft & Roodt, 2013). For example, individuals with high 
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working memory skills but different spoken languages should obtain the same or similar 
scores on the different language versions of an assessment instrument for working 
memory. 
Considering the broader impact of cultural-sensitivity in neuropsychological 
assessment, Greenfield (1997) emphasises that assessment instruments are implicitly based 
on assumptions about values, knowledge and communication. If instruments are used on 
individuals from a culture that have different values, knowledge and communication than 
that which the instruments assume, the validity of the assessment is undermined. Ardila 
(2005) builds on this view by presenting specific culturally-determined aspects that are 
important to consider with neuropsychological assessment. He explains the unique way an 
individual relates to other people and persons from outside their culture is determined by 
cultural values. Moreover, the emphasis and specifics of background authority differ from 
one culture to another. For example, in a typical neuropsychological assessment situation, 
the test administrator is required to give instructions to the test subject and the test subject 
is expected to carry out (follow or obey) these instructions. Intuitively, behaviour will be 
influenced by the role the test taker assumes and, in this way, performance scores may be 
affected by culturally based realities about authority (Wong & Fujii, 2004). The notion of 
best performance also differs from one culture to another. Specifically, a culture that is 
highly competitive will have a different value attached to what is considered best 
performance than a less competitive culture (Ardila, 2005). Robertson et al. (2009) 
explains this with the observation that some cultures may consider thoughtful, cautious and 
deliberate actions as best performance, whereas other cultures may place an emphasis on 
accuracy at the highest possible speed for best performance. This is also closely related to 
the subjective experience of time and speed, which varies significantly across different 
cultures (Ardila, 2005). Neuropsychological assessment instruments with performance 
scores based on the speed of completing a task, for example the Trail-Making Test, may be 
influenced by this cultural value (Agranovich et al., 2011). Furthermore, the assessment 
environment and acceptable standards of this environment should also be considered. For 
example, in some cultures the private assessment environment, with the test taker and 
administrator in an isolated room, may be inappropriate (Ardila, 2005). In terms of 
communication, this goes beyond verbal language and special types of communication are 
uniquely determined by culture and cultural settings. The latter will have a significant 
impact on the validity of assessment that rely heavily on the use of formal verbal language 
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(Ardila, 2005). Finally, the knowledge dimension of culture has an impact on 
neuropsychological assessment because the process of knowing and the object of 
knowledge is culturally dependent (Greenfield, 1997). For instance, familiarity differs 
considerably between cultures for physical elements such as figures, objects, blocks and 
pictures (Rosselli & Ardila, 2003). This, once again demonstrates the importance of 
equivalence. 
2.3.4 Neuropsychological Domains 
The current systematic review will include studies using a myriad of 
neuropsychological assessment instruments and these instruments, in turn, measure various 
neuropsychological domains. As mentioned in the previous section, the specific domains 
of functioning are sampled to make inferences about normal and atypical functioning 
(Schoenberg & Scott, 2011). These domains are based on three functional systems 
according to Lezak et al. (2012), namely cognitive functions, emotionality and executive 
functions.  
 For heuristic purposes, I first present the perception-action cycle to conceptualise 
the operation of the functional systems and to further demonstrate how these systems are 
integrated. In short, Fuster (2004, 2017) describes this neurofunctional framework as the 
flow of information from the environment (either the external environment or internal 
feedback) to sensory structures (posterior cortex); then, from sensory structures to motor 
structures (anterior cortex), and back again to the environment, continuously updating in a 
circular fashion. The flow of information and formation of memory occurs hierarchically 
along the cerebral cortex. The highest level of this hierarchy is the prefrontal cortex 
implicated in complex schemas and plans of goal directed action which require temporal 
integration and organisation of behaviour (Fuster, 2004, 2017).  
 In terms of the cognitive functions, Lezak et al. (2012) provide a description of 
four constituent sub-domains, namely: receptive functions, memory, thinking and 
expressive functions. (1) Receptive functions are the selection, acquisition, classification 
and integration of information. This includes sensory processes and perception. (2) 
Memory and learning pertain to the storage and retrieval of information (for which the 
receptive functions are a prerequisite). (3) Thinking overlaps with executive functions; 
however, thinking is a narrower construct defined as the organization and reorganisation of 
information. Lastly, (4) expressive functions are the direct observable behaviours such as 
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speaking, writing, drawing, manipulation, gesturing and facial movements. Mental 
activities are explained by making inferences about expressive functions. In essence, the 
four sub-domains of cognition answer the general questions of How much? and What?, for 
example: “How much do you know?” and “What can you do?” (Lezak et al., 2012). 
The functions of emotionality include the domains of emotions, mood, volition and 
motivation. Historically, the construct emotion has been difficult to define; however, in a 
general sense, the term is used for any of several subjectively experienced states (Reber & 
Reber, 2001). With a more precise view, affective neuroscience defines emotion as the 
ability to subjectively experience certain states of the central nervous system (Panksepp, 
2004). In addition, the motivation to act on any behaviour is determined by emotional 
weight and, subsequently, this determines volition. Volition is the capacity for intentional 
behaviour through the process of determining what is needed or wanted and cognitively 
conceptualising a future realization. It, therefore, requires the capacity to formulate a goal; 
and apathy, with diminished or even absent capacity for emotional response, is typical in 
volitional impairment (Lezak et al., 2012).  
Executive functioning is the third functional system and can be described as 
purposive, future-oriented or goal-oriented behaviours (Goldberg, 2017). As executive 
functioning is central to the current systematic review a detailed discussion is provided in 
section 2.4.  
On a final note, the variables of mental activity are the level of consciousness, 
arousal and alertness; attentional functions; and activity rate (or speed of processing). In 
short, these variables constitute the efficiency of the functional systems (Lezak et al., 
2012) and although the variables of mental activity are not specific domains, these 
variables are important when conducting neuropsychological assessment. 
2.4 Executive Functions 
2.4.1 Introduction 
In this section, a number of definitions as well as the historical development of 
executive functions as a scientific construct are discussed in terms of the most prominent 
theories available. Thereafter, the various subcomponents of executive functions are 
delineated and contextualised and the brain-behaviour relationship of executive functions 
is presented based on available neuropsychological and neuroimaging research. The 
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prominent neuropsychological assessment instruments used to measure executive 
functions is outlined and some of the major measurement issues are presented. The section 
concludes with a discussion on the importance and relevance of executive functioning. 
2.4.2 Definition and Description of Executive Functioning 
In a comprehensive review, Jurado and Rosselli (2007) describe executive 
functioning as enabling the individual to shift mental attention for adaptive responses, 
while simultaneously inhibiting inappropriate behaviours, within a constantly changing 
environment. Furthermore, executive functions allow the individual to formulate future-
oriented, goal-directed plans, initiate execution and persevere until completion. The 
Encyclopedia of Clinical Neuropsychology (Stern et al., 2017) describes executive 
functioning as a multifaceted construct. It encompasses a collection of sophisticated 
mental abilities underlying independent goal-directed behaviours, problem-solving and the 
efficiency of knowledge accumulation. Therefore, this broad construct includes abilities 
such as initiation, planning, organising, working memory, attention, mental flexibility, 
inhibition, emotional regulation and self-monitoring. Lezak (2012) describes executive 
functioning as the successful engagement in independent, purposive, self-directed and self-
serving behaviours by an individual and includes the domains of planning, decision 
making, purposive action, volition and effective performance. Executive dysfunction, even 
to a lesser extent, is directly correlated to impairment in basic day-to-day functioning 
(Lezak et al., 2012).   
2.4.3 Models of Executive Functioning 
Various models and theories of executive functioning have been developed and, 
notably, these complement each other. The models may differ in the level and scope of 
analysis but at the same time, when considered collectively, complete a greater picture of 
this highly complex construct. I briefly discuss the most prominent models of executive 
functioning and present the central tenet of each model in Table 2.1.  
In 1973 Alexander Luria published The Working Brain: An Introduction to 
Neuropsychology. At the time, he proposed that the human brain is comprised of three 
basic functional units. The brain stem maintains arousal of the cortex; the parietal, 
temporal and occipital lobes are responsible for the encoding, processing and storage of 
information; and the programming, regulation and verification of behaviour occur within 
the frontal lobes (Chan et al., 2008). It was only in 1974, however, that the construct 
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executive function originated from the central executive component of Baddeley and 
Hitch’s working memory model (Jurado & Rosselli, 2007). Baddeley and Hitch (1974) 
proposed that working memory is made up of different components: the visuospatial 
sketchpad, the phonological loop, the central executive and the episodic buffer. The 
visuospatial sketchpad retains visual and spatial information for a brief period. The 
sketchpad contains two distinct components: The first component retains information for 
specific features of an object and the second component retains sequential spatial 
information. The phonological loop holds inner speech for a brief period, and can be 
further divided according to the functions of phonological storage and subvocal rehearsal. 
The central executive coordinates activities of attention and governs responses. In 
conjunction, the episodic buffer integrates information between the visuospatial sketchpad, 
the phonological loop and long-term memory (Sternberg & Sternberg, 2012). 
In 1983, Lezak defined the construct of executive function as the dimension of 
human behaviour that deals with “how” behaviour is expressed (Jurado & Rosselli, 2007). 
Specifically, the delineated sub-domains of volition, planning, purposive action and 
effective performance can be evaluated by observing expressive behaviours linked to these 
domains and making appropriate inferences (Lezak et al., 2012). Around the same period, 
in 1986, Norman and Shallice introduced the supervisory attentional system model (Chan 
et al., 2008; Norman & Shallice, 1986). Building on Luria’s notion of frontal lobe 
functioning, this model proposed that the programming, regulation and verification of 
human behaviours involve two systems. The first, the contention scheduling system is 
responsible for routine and overlearned behaviours and the order of these behaviours are 
prioritised. The second, the supervisory attentional system, regulates non-routine and novel 
behaviours (Jurado & Rosselli, 2007). Norman and Shallice (1986) further proposed that 
situations which require the supervisory attentional system will include the following: (1) 
planning or decision-making; (2) troubleshooting or error correction; (3) responses 
containing unfamiliar or novel sequences of actions; (4) anticipated danger; (5) overriding 
a strong habitual response or resistance to temptation. Also in 1986, the tripartite model 
was introduced which comprises three interactional systems. The first two, the anterior 
reticular activating system and the diffuse thalamic projection system, primarily maintain 
arousal. The fronto-thalamic gating system is implicated in attention and executive 
functions (Chan et al., 2008). This model was expanded later and the schema was 
introduced which is a network of neurons activated by sensory input, other schemata, or 
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the executive control system (Stuss et al., 1995). On a neural level different attention and 
executive functions are identified: sustained attention correlates with the right frontal lobe; 
concentration with the cingulate area; divided attention with the cingulate area and 
orbitofrontal cortex; suppression with the dorsolateral prefrontal cortex; switching with the 
dorsolateral prefrontal cortex and medial frontal areas; preparation with the dorsolateral 
prefrontal cortex; and goal setting with the left dorsolateral prefrontal cortex (Chan et al., 
2008). 
It is well understood that emotion is also mediated in frontal regions. Marked 
emotional and social impairment is observed in ventromedial frontal cortex damage; 
particularly, the cortical links between ventromedial cortex and the subcortical links of 
mediodorsal nucleus of thalamus, amygdala and hypothalamus (Chan et al., 2008). Based 
on the latter, Damasio (1996) introduced the importance of emotions in relation to 
executive functioning . The somatic markers model is grounded in the findings that 
ventromedial damage impairs the ability to mark inappropriate behaviour with an emotion-
related somatic signal even though the individual might be able to understand the 
implications of such behaviours. These individuals will show difficulties in regulating their 
behaviours because they could not make use of emotional-related somatic markers. 
According to the goal-neglect theory (Duncan et al., 2008), human behaviour is 
goal-oriented and specific goals contain subordinate lists or sub-goals. Moreover, goals are 
formulated, stored and monitored in the mind for the individual to behave optimally in 
response to environmental and internal demands. One of the main functions of goals is to 
impose a structure on behaviour by determining the activation or inhibition of behaviour 
that either promotes or prevents task completion (Chan et al., 2008).  
Miyake et al. (2000) found both unity and diversity are evident in executive 
functions. That is, different executive functions correlate with one another (unity) but also 
show separability (diversity). The three executive functions investigated in this model are 
updating, shifting and inhibition. Updating is defined as the continuous monitoring and 
rapid addition and/or deletion of working memory contents; shifting is flexible switching 
between tasks or mental sets; and, inhibition is the deliberate overriding of dominant 
responses (Miyake & Friedman, 2012). The authors of this model acknowledge executive 
functions other than the three used in the unity/diversity model and emphasise that the 
specific constructs used depend on the level of analysis. For example, planning as an 
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executive function is regarded as a higher-level construct which includes all three 
constructs of updating, shifting and inhibition. These three constructs can be further 
decomposed into lower-level subconstructs. For example, updating can be decomposed 
into monitoring, addition, active maintenance, and deletion (Miyake & Friedman, 2012). 
Fuster (2017) provides a comprehensive explanation of executive functioning using 
the perception-action cycle as a neurofunctional framework. This cycle is the circular 
processing of information with the aim being the adaptation of the organism to its 
environment. The prefrontal cortex plays a crucial role in the temporal organisation of 
behaviour and language by the preadaptation of the organism to internal or external events 
before they happen (Fuster, 2004). This can be regarded as a functional description of 
executive functioning which includes three major executive functions. The three major 
executive functions are executive attention, working memory and decision making. 
Executive attention, or attentional set, is the priming of sensory and motor systems for an 
anticipated and predictable adaptive response to a stimulus. Working memory is the 
temporary retention and manipulation of information for executing an action (performing a 
task or solving a problem) in the near future. Purpose and intentionality differentiate 
working memory from other forms of short-term memory. Decision making involves an 
intentional choice of prospective action among various alternatives. All three of these 
functions have a future-oriented purpose (Fuster, 2017). The central tenets of each of these 
various models of executive functioning are summarised in Table 2.1. 
Table 2.1 
Models of Executive Functioning 
Model Central tenet of executive functioning 
Luria’s working brain The programming, regulation and verification 
of behaviour occur within the frontal lobes. 
Baddeley and Hitch’s working memory The central executive coordinates activities of 
attention and governs responses. 
Lezak’s expression of behaviour Sub-domains of volition, planning, purposive 
action and effective performance constitute 
executive functioning. 
Norman and Shallice supervisory attentional 
system 
Non-routine and novel behaviours are 
regulated by a supervisory attentional system. 
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Stuss and Benson tripartite model The neurophysiological fronto-thalamic gating 
system is implicated in attention and executive 
functions. 
Damasio’s somatic markers Behaviour is marked with an emotion-related 
somatic signal with direct implications for 
executive functioning. 
Duncan’s goal-neglect theory Goals are formulated, stored and monitored in 
the mind for the individual to behave optimally 
in response to environmental and internal 
demands. 
Miyake and Friedman’s unity/diversity model Different executive functions correlate with one 
another (unity) but also show separability 
(diversity). 
Fuster’s perception/action cycle The prefrontal cortex plays a crucial role in the 
temporal organisation of behaviour and 
language by the preadaptation of the organism 
to internal or external events before they 
happen. 
 
In conclusion, it is evident that the various models differ in the level of analysis 
and specific definitions; however, Jurado and Rosselli (2007) note that despite these 
differences, an agreement exists in the complexity and significant importance of executive 
functions for human adaptive behaviour. Nonetheless, until a consensus is reached, the use 
of these various models also necessitates that research studies should specify the level and 
scope of analyses when investigating executive functioning. 
2.4.4 Current Understanding of the Neurophysiology of Executive Functions  
Thus far, the executive functions have been explained based on various theoretical 
models. However, because neuropsychology is grounded in the neurological basis of 
behaviour it is necessary to outline the current understanding of the neurophysiology of 
this construct. Historically, with the modular view of the brain, it was believed that 
executive functioning is narrowly associated with the frontal cortex. However, with 
advances in neuroscience, research suggests that executive functioning can be explained 
by a number of neural networks and areas of the brain (Stern et al., 2017). Based on human 
lesion and neuroimaging studies, prefrontal areas with respective connections to striatal 
and limbic regions, are linked to specific executive functions (Verdejo-Garcia, 2017). 
Specifically, the sub-domains of working memory is associated with the dorsolateral 
prefrontal cortex (Bogdanov & Schwabe, 2016); decision making with the medial 
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orbitofrontal cortex (Bechara, 2000; Rolls & Grabenhorst, 2008); response inhibition with 
the inferior frontal gyrus (Aron et al., 2014); and cognitive flexibility with the ventrolateral 
prefrontal cortex (Hampshire et al., 2008). The neurophysiology of executive functioning 
is highly relevant to the development of substance dependence and addiction and discussed 
in section 2.5. Furthermore, there is a bidirectional relationship between 
neuropsychological assessment and our understanding of the neurophysiology of the 
executive functions because these inform one another. 
2.4.5 Assessment of Executive Functions 
To recap, executive functions can be psychometrically distinguished from 
cognitive functions. Assessment of executive functions is based on how or whether a 
person presents behaviour, whereas the assessment of cognitive functions involves what or 
how much a person presents behaviour (Lezak et al., 2012). Although executive 
functioning is regarded as one of the most complex human activities, there are several 
measurement techniques available to allow for the observation of behaviours associated 
with underlying executive functions. The main techniques are neuropsychological 
assessment, neuroimaging (such as computerised tomography) and neurofunctional 
assessment (for example, functional magnetic resonance imaging). For the purpose of the 
current systematic review, only neuropsychological assessment is discussed.  
There are many neuropsychological instruments and batteries used to measure 
executive functioning. The most prominent of these, as depicted by Lezak et al. (2012) and 
Strauss et al. (2006), are the Wisconsin Card Sorting Test, the Stroop Test, the Trail 
Making Test, the Controlled Oral Word Association Test, the Hayling Sentence 
Completion Test, the Brixton Spatial Awareness Test, the Tower of London and the Tower 
of Hanoi. The Wisconsin Card Sorting Test assesses shifting, maintenance, and inhibition 
of the cognitive functions of rule detection and concept formation. Four stimulus cards are 
placed in front of the subject. The objects printed on the cards vary in shape, colour and 
number. The subject is given a deck of similar cards and instructed to arrange the cards 
under the stimulus cards according to an unknown rule that changes after every six 
placements without warning (Jurado & Rosselli, 2007; Lezak et al., 2012; Strauss et al., 
2006). The Stroop Test assesses inhibition, but also processing speed as a mental activity 
variable. The subject is required to read a list of colour words printed in black ink as fast as 
possible while being timed. Thereafter, the colour of a list of X’s should be named as fast 
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as possible while being timed. Finally, the printed colour of a list of words should be 
named as fast as possible, ignoring the incongruent colour words. For example, if the word 
BLUE is printed in green ink, the subject is required to say “green” and inhibit the 
prepotent response (more powerful impulse) of saying “blue” (Jurado & Rosselli, 2007; 
Lezak et al., 2012). The Trail Making Test is comprised of two parts and measures shifting 
and inhibition. In the first part the subject is required to connect a sequence of encircled 
numbers with a pencil, as fast as possible. In the second part the subject is required to 
connect a sequence of encircled numbers but alternating between two different circle 
colours – inhibiting the prepotent response to connect the same coloured circles which are 
also printed on the page (Jurado & Rosselli, 2007; Lezak et al., 2012; Strauss et al., 2006). 
The Controlled Oral Word Association Test is a verbal fluency test and measures 
inhibition. The subject is instructed to name as many words as possible beginning with the 
letter F; thereafter the same instruction is given for the letter A and then the letter S. 
However, proper nouns, repeated words, colours and derivatives of the same word stem 
are not allowed (Jurado & Rosselli, 2007; Lezak et al., 2012; Strauss et al., 2006). The 
Hayling Sentence Completion Test has two parts. The subject is required to complete 
sentences with the last word missing. For the first part the word should make sense; 
however, the second part requires a word that does not match the context of the sentence – 
thereby requiring inhibition of the sensible response (Jurado & Rosselli, 2007; Strauss et 
al., 2006). The Brixton Spatial Awareness Test requires the subject to predict the position 
of a coloured circle from one page to the next. The subject does not know the rules. This 
assesses rule detection which includes updating and working memory maintenance (Jurado 
& Rosselli, 2007; Strauss et al., 2006). The Tower of London is a puzzle assessing decision 
making, planning and inhibition. The subject must determine the order of moves required 
to rearrange several rings to a new predefined arrangement. Only one ring may be moved 
to any of the two alternative pegs until the rings are rearranged as required (Jurado & 
Rosselli, 2007; Lezak et al., 2012). The Tower of Hanoi is a more difficult version of the 
Tower of London. Using the same rules, these rings are of different sizes and the subject is 
further required to order the rings according to size. 
As with any scientific measurement, there are certain limitations to consider. The 
task-impurity problem is one of the primary caveats of executive function assessment. 
Task-impurity is a systematic non-executive function variance and measurement error 
which makes it difficult to accurately measure the executive function variance of interest 
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(Miyake & Friedman, 2012). For example, the Wisconsin Card Sorting Test discussed 
above includes systematic variance attributable to non-executive function processes, such 
as colour and form processing, sensory-motor functions and visuospatial abilities. In order 
to minimise this problem, the latent-variable approach can be used. In this approach 
multiple exemplar instruments are selected. The tasks of these instruments seem different 
at face value but capture the target ability. Multivariate statistical techniques such as 
confirmatory factor analysis and structural equation modelling can then be used to extract 
what is common across the different tasks (Miyake & Friedman, 2012). Other limitations 
include the possibility of assessment measures not being culturally sensitive, a shortage of 
normative data for specific populations being assessed and the estimation of premorbid 
functioning (Lezak et al., 2012). 
2.4.6 Relevance of Executive Functions 
Lezak et al. (2012) explain that considerable loss of cognitive functions with intact 
executive functions allows the individual to continue to be independent, purposive, self-
directed and self-serving. However, the loss of executive functions, even to a small extent, 
can cause impairment in these capabilities and present as problems with self-care, 
independent work and social relationships – regardless of preserved cognitive functions. It 
is clear, therefore, that executive functioning is fundamental to every aspect of human 
functioning. As explained by Diamond (2013), research has demonstrated how executive 
functioning is relevant to various aspects of life, including mental health (Malloy-Diniz et 
al., 2017), physical health (Mora-Gonzalez et al., 2019), educational performance (Gordon 
et al., 2018), job performance (Culbertson et al., 2013), quality of life (Love et al., 2016; 
Stern et al., 2017) and even public safety (Meijers et al., 2017; Seruca & Silva, 2016). In 
terms of substance dependence, executive function impairment is central to relapse and 
continued use through the loss of control over cravings and increased impulsivity. 
Specifically, the impairment of decision making, self-regulation, inhibition and working 
memory are directly linked to excessive salience attribution for substance-related cues and 
decreased abilities to inhibit maladaptive behaviours (Goldstein & Volkow, 2011;Koob & 
Volkow, 2016). The relevance of executive functioning in substance dependence, with 
reference to the specific substances, is discussed in detail in section 2.5.  
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2.5 Substance Dependence and Executive Functions 
2.5.1 Introduction 
The bidirectional manifestation of executive function impairment and addiction, as 
posited by the brain disease model, is explained in section 2.2.6. The focus in this section 
is the substance-specific effects on executive functioning and related neuropsychological 
domains based on existing research. The most comprehensive review of its kind 
(Fernández-Serrano et al., 2011) investigated the effects of cannabis, cocaine, 
methamphetamine, MDMA (ecstasy), opioids and alcohol on neuropsychological 
performance. In general, matched healthy control groups were used as comparators in the 
included studies of this review with one longitudinal study controlling for premorbid 
functioning by means of multiple assessment intervals. The study reports that even with 
the use or abuse of a primary substance, in the majority of cases, more than one substance 
is used simultaneously. This makes it challenging to establish correlations between 
specific substances and neuropsychological performance. However, to account for this, the 
review included three different methodologies and found for all substances examined a 
significant effect on the neuropsychological domains of episodic memory, emotional 
processing, updating and decision making. With a higher reliability, correlations between 
specific substances and distinctive neuropsychological domains were discovered. These 
findings, together with results from other studies, are discussed below. 
2.5.2 Alcohol and Executive Functions 
Alcohol dependence has been found to impair processing speed, abstract reasoning, 
inhibition, endurance, memory, learning and planning (Punzi, 2015). Moreover, impaired 
spatial processing, reduced perceptual speed, selective attention, cognitive inflexibility and 
increased impulsivity were found in a synthesis of empirical studies (Fernández-Serrano et 
al., 2011). A recent meta-analysis by Stephan et al. (2017) examined the effects of alcohol 
on specific subcomponents of executive functioning. The impact of alcohol abuse on 
planning, problem solving, and inhibition was found to be significant. In another meta-
analysis Stavro et al. (2013) examined the cognitive impairment caused by alcohol 
dependence and the duration necessary for recovery from this impairment. Moderate effect 
sizes, determined by Cohen’s d, for the domains of executive functioning were found for 
short-term (<30 days), intermediate-term and long-term (>365 days) abstinent participants. 
It is, however, possible that withdrawal may have had an impact on the performance of 
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individuals. Therefore, it is important to account for this confounding variable when 
interpreting the findings. 
2.5.3 Cannabis and Executive Functions 
With early onset and chronic use, the effects of cannabis on attention, memory and 
executive functioning are significant. Furthermore, the effects of cannabis may be 
prolonged as some persistent impairments may be diffuse and subtle. Emotional 
functioning may also be impaired as individuals present with emotional numbing and 
amotivation (Punzi, 2015). A review of empirical studies found impairments in prospective 
memory, processing speed and complex planning with cannabis use (Fernández-Serrano et 
al., 2011). In addition, a recent review of meta-analytic studies by Verdejo-Garcia (2017), 
concluded that chronic cannabis use correlates with impairment of decision making and 
complex planning. This review also reports on findings that individuals with early-onset 
use in adolescence and those with genetic predisposition (val/val genotype of the COMT 
gene; short/short genotype of the SLC6A4 gene) have further impairments of decision 
making, sustained attention, response inhibition and flexibility. Another recent systematic 
review on the acute and chronic effects of cannabinoids on cognition reported mixed 
findings for the chronic effects of cannabis on executive functions (Broyd et al., 2016). 
The evidence for recovery of functions with abstinence was both mixed and at times 
insufficient. The reviewers also reported on the high heterogeneity in both sample 
demographics, especially high variance in substance exposure, and the assessment of 
cognitive domains. The effects of organic and synthetic cannabinoids on executive 
functions were recently investigated by systematic reviewing of both pre-clinical and 
clinical studies (Cohen & Weinstein, 2018). Findings demonstrate an association between 
repeated consumption of cannabinoids and impairment of executive functions. High 
heterogeneity was found in the samples in terms of the type of drug, the dosage, the age of 
onset and the duration of use. An earlier meta-analysis investigated the residual effects of 
cannabis use after abstinence on neurocognitive performance (Schreiner & Dunn, 2012). In 
this meta-analysis rigorous inclusion criteria were used to ensure generalizability. The 
study found a small negative effect for the first 25 days of abstinence, which may be 
attributed to either residue cannabis or withdrawal effects. However, no evidence was 
found for enduring negative effects. It therefore appears that the empirical evidence 
regarding the impact of cannabis on executive functioning is somewhat mixed, with most 
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studies reporting impairment in specific domains; however, the effects of various 
confounders remain unclear. 
2.5.4 Hallucinogens and Executive Functions 
A literature search was conducted and no systematic reviews were found that 
explicitly investigate the effects of the hallucinogens on executive functioning. However, a 
systematic review was found that report on some findings for neuropsychological 
functioning. dos Santos et al. (2016) synthesised empirical studies of the psychiatric 
symptoms, neuropsychological functioning, and neuroimaging of ayahuasca (a 
psychoactive brew originating in South America) and reported that certain positive effects 
were found. With acute use, ayahuasca was found to improve planning, inhibitory control 
and working memory impairment. Subacute and long-term use showed enhanced cognition 
and reduced impulsivity. The authors further report, however, that some methodological 
limitations were found in the studies and that replication is necessary. 
In general, research is sparse that investigate the relationship between executive 
functions and dependence on hallucinogens such as ayahuasca, dimethyltryptamine 
(DMT), psilocybin, lysergic acid diethylamide (LSD), mescaline, dextromethorphan, 
ketamine, phencyclidine (PCP) and salvia divinorum. This may be because of the low 
prevalence in comparison to other substance classes. The United Nations Office on Drugs 
and Crime (2017) reports that the global average of people seeking substance-related 
treatment for hallucinogens is less than one per cent. 
2.5.5 Inhalants and Executive Functions 
Among the inhalant substances containing aromatic hydrocarbons such as styrene, 
xylene, n-hexane and toluene, the latter has the highest potential for abuse. Glue, lacquer 
and spray paint are toluene-rich industrial products. Even though existing research is 
scarce, existing studies show chronic inhalation of toluene has significant neurobiological 
and neuropsychological impairment as reported in a review by Yücel, Takagi, Walterfang 
and Lubman (2008). The review further reports that the included studies had findings of 
impairments in processing speed, sustained attention, memory retrieval, language 
processing and general executive functioning. 
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2.5.6 Opioids and Executive Functions 
Existing studies indicate that opioids impair spatial and visual memory, impulse 
control, attention, and overall executive functioning. The same impairments also present 
with individuals undergoing methadone treatment (Punzi, 2015). According to a review of 
meta-analytic studies, chronic opioid use is linked to significant impairment in working 
memory and decision making, specifically for heroin and methadone. Prescription opioid 
drugs have not shown any significance based on the available research (Verdejo-Garcia, 
2017). Furthermore, studies investigating the effects of long term abstinence indicate 
impairment in updating and decision-making as possible persistent opioid-related effects 
(Fernández-Serrano et al., 2011). 
2.5.7 Sedatives, Hypnotics, Anxiolytics and Executive Functions 
A literature search was conducted and no systematic reviews were found which 
explicitly investigate the effects of the sedatives, hypnotics or anxiolytics on executive 
functioning. This is noteworthy, as this substance class accounts for four per cent of the 
global average of individuals seeking substance-related treatment (United Nations Office 
on Drugs and Crime, 2017) which is a significant proportion. After a comprehensive 
search of the literature, the current systematic review may reveal to what extent this 
substance class has been investigated in relation to executive functioning. 
2.5.8 Stimulants and Executive Functions 
Working memory, attention and general executive functions are impaired by 
stimulants (Jovanovski et al., 2005; Lundqvist, 2005; Punzi, 2015; Wunderli et al., 2017). 
In addition, stimulants have a considerable effect on emotional, motivational processes and 
the capacity to remember future intentions (Punzi, 2015). Spatial processing, perceptual 
speed, processing speed, selective attention and complex planning impairments have been 
reported with chronic MDMA (ecstasy) use (Fernández-Serrano et al., 2011). 
Concurrently, it is reported in a review of meta-analytical studies that chronic cocaine use 
correlates with significant impairment in working memory and high perseveration (from 
reward-related inflexibility). Response inhibition and decision making are also impaired; 
however, these may be premorbid deficits (Verdejo-Garcia, 2017). In the same review, 
chronic methamphetamine use is reported to be linked with deficits in various executive 
functioning domains but these are in isolated studies and robustness is questioned, 
prompting further research (Verdejo-Garcia, 2017). Studies investigating effects with long 
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term abstinence indicate impairment in updating, inhibition, cognitive flexibility and 
emotional processing as possible psychostimulant-related effects (Fernández-Serrano et 
al., 2011). 
2.5.9 Nicotine and Executive Functions 
There appears to be a relationship between nicotine dependence and executive 
functioning (Fernández-Serrano et al., 2011; Flaudias et al., 2016). However, no 
systematic review is available in the literature that report on empirical studies that 
investigate the effects of nicotine on neuropsychological performance. The current 
systematic review may provide an overview of the extent of the current available evidence 
with regard to the relationship between nicotine and executive functioning. 
2.5.10 Conclusion 
The effects of the various classes of substances on executive functioning and 
related neuropsychological domains were presented based on existing reviews. It is evident 
that confounding variables need to be considered when interpreting results. For example, 
where the effects of a substance on neuropsychological performance are investigated, 
withdrawal may also have an effect on the results. Furthermore, studies within reviews 
have mixed findings and predominantly because of high heterogeneity in terms of 
substance type, dosage and frequency, age of onset and duration of use. Existing empirical 
studies of the neuropsychological effects of certain substance classes have not been 
systematically reviewed. In terms of the specific scope, no systematic reviews were found 
for hallucinogens; sedatives, hypnotics and anxiolytics; and tobacco. 
2.6 Conclusion  
In this chapter, I presented a theoretical review as a precursor to and conceptual 
framework for the systematic review which follows in Chapters 3 and 4. It is evident from 
the theoretical review that there are sophisticated empirically supported models of both 
substance dependence and executive functions, together with well-refined measurement 
techniques for assessing executive functions and other neuropsychological constructs. 
However, limited work appears to have been done in terms of evaluating and synthesizing 
the available empirical evidence regarding the relationship between substance dependence 
and executive functions. I address this gap in the following chapters. 
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Chapter 3: Research Methodology 
3.1 Introduction 
In this chapter I describe the general research approach adopted, as well as the 
specifics of how it was applied to the current study. Because systematic reviews are still 
relatively uncommon in psychology, I present the conceptual basics of systematic review 
methodology in some detail, together with a description of the techniques of applying it in 
practice. 
3.2 Research Approach: Systematic Review 
3.2.1 Introduction 
In this section the theoretical basis of the systematic review as a research 
methodology is discussed. The methodology is presented in terms of its historical 
development, its distinctive methods and processes, the strengths and limitations of 
conducting a systematic review, aspects of methodological quality and, to conclude, a 
comparison of the different review types. 
3.2.2 Definition and Description 
 It is crucial for policymakers and professionals to keep up to date with advances in 
their fields. However, the amount of available research is increasing exponentially and 
makes it practically impossible to keep abreast of all information. Systematic review 
methodology alleviates this issue to some degree by synthesising large bodies of research. 
In this way, it can elucidate what works and what does not work in order for researchers 
and practitioners to allocate scarce resources most effectively (Higgins et al., 2019). 
According to Boland et al., (2017), a systematic review is a rigorous literature 
review with the primary aim of providing evidence-based answers to research questions. 
This is done by locating, appraising and synthesising the best available evidence from the 
literature by means of methods designed to minimise bias. Furthermore, a systematic 
review follows stages that are well-defined and transparent. This ensures the legitimacy of 
the identification of available evidence. It also ensures accurate synthesis of the findings to 
provide relevant conclusions. These stages follow a logical course, but also inform one 
another throughout the process (Boland et al., 2017; Gough et al., 2012). 
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3.2.3 Historical Development 
The methodology of synthesising previously published research reports is not new. 
Even as early as 1753, James Lind conducted research into scurvy prevention by carefully 
specifying his search strategy and extracting relevant data from the available publications 
(Chalmers, 2003). However, the basic tenets of the methodology were only formally 
established by two individuals in the 1970s: In 1972, Archie Cochrane proposed that 
because healthcare resources are limited it is necessary to properly evaluate the clinical 
effectiveness of any form of healthcare before use. He regarded randomised controlled 
trials (RCTs) as the best available evidence for this purpose (Cochrane, 1972). Within the 
next few years, Gene Glass conducted research which resulted in the development of 
statistical techniques to combine the results of independent studies, known as meta-
analysis (Glass, 1976).  
Recognition grew internationally following the groundwork laid by these 
prominent researchers and in 1992 the Cochrane Collaboration was established. At the 
time of writing, the collaboration comprises of an international network with thousands of 
dedicated individuals in more than 130 countries who work together for well informed 
decisions about healthcare (The Cochrane Collaboration, 2019). The methodology has also 
expanded to other fields such as the Campbell Collaboration that was established in 2000 
with reviews focussing on the effects of social interventions in areas such as education, 
crime and justice (Boland et al., 2017; Campbell Collaboration, 2019). 
3.2.4 Essential Methods 
A systematic review follows a specific process that is well-defined and transparent. 
The stages of this process are illustrated in Figure 3.1. First, for a systematic review to 
adhere to the rigour and transparency of scientific inquiry, it is required to develop a 
detailed protocol. The protocol contains a clearly defined and well-focused research 
question and explicit, predefined methods for the literature search, screening and selection 
of studies, data extraction, quality assessment, data analysis and synthesis. Second, a 
literature search is conducted with an exhaustive list of key search terms which will ensure 
the highest probability of locating all relevant studies (Gough et al., 2012; Shea et al., 
2017). Furthermore, the most appropriate databases should be selected based on the field 
of inquiry and at least two databases should be used to search for publications (Shea et al., 
2017). Third, studies from the search results are screened and selected using clear 
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inclusion and exclusion criteria. These criteria are formulated in terms of various study 
characteristics (e.g., populations, study designs, etc.). The degree of specificity with which 
these criteria are defined is determined by the depth and breadth of inquiry required to 
answer the review questions. 
Figure 3.1 
Stages of the Systematic Review 
 
Fourth, after the relevant studies have been selected the data are extracted from the 
included studies and tabulated. Fifth, quality assessment is conducted which can be done 
both prior to and after data extraction. The benefit of doing quality assessment after data 
extraction is that the reviewers are more familiar with the specific data and thereby better 
able to identify quality aspects of the studies. However, it is possible, where quality 
assessment is only done after data extraction, that unnecessary data extraction is done from 
studies that might have been excluded based on quality criteria. Important elements that 
are considered in the quality assessment of studies are discussed in section 3.2.6 of this 
chapter. Finally, the extracted data from the independent studies are then combined and 
analysed to describe and summarise the gathered information. This is known as a narrative 
synthesis and is a requirement of a systematic review. Systematic reviews that focus purely 
on quantitative findings often make use of statistical meta-analysis but this is only feasible 
for data with low heterogeneity at face value. Whether conducting a narrative synthesis or 
a meta-analysis, the findings of a systematic review allow adequate comparisons to be 
made and the identification of possible consensus or near-consensus findings and 
inconsistencies. It may also be possible to uncover gaps and exhaustive evidence in the 
available research.  
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    search1. Protocol
6. Analysis and  
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3.2.5 Strengths and Limitations 
 Systematic review methodology is considered the gold standard to synthesise 
studies investigating the same problem or question. In the United Kingdom, systematic 
reviews form the basis of clinical practice based on the National Institute for Health and 
Care Excellence Guidelines (Boland et al., 2017). The World Health Organization also 
uses systematic reviews to formulate standard international guidelines. Any implemented 
guidelines are required to be supported by at least one systematic review of the evidence 
(World Health Organization, 2014). 
There are various scientific benefits to using a systematic review as a research 
methodology. The methodology is explicitly reproducible as the protocol provides 
predefined methods that are followed which ensure that bias is minimised in the study. 
These methods include a systematic search and selection of studies based on predefined 
eligibility criteria and clear objectives. Included studies are quality assessed using tools 
specifically designed for this purpose and the findings are also synthesised and presented 
systematically. All of these features optimise the scientific rigour and transparency of the 
review. Furthermore, the findings of a systematic review are also used to advance the 
respective field of enquiry; informing future practice and research; and, when combined 
with professional judgement, informing interventions and policies (Perrier et al., 2011). Of 
utmost importance, the evidence from systematic reviews can be used to ensure that scarce 
resources are allocated more effectively (Higgins et al., 2019). 
A systematic review has a specific scope and may be limited or strengthened by the 
depth and breadth of investigation (Gough et al., 2012). A narrow and in-depth review may 
be limited by excluding important confounding data which a broad and general review 
may include; in contrast, a broad and general review may be limited by failing to provide 
precise and explicit outcomes which a narrow, in-depth review may provide. This is 
explained in more detail in section 3.2.7 of this chapter.  
3.2.6 Methodological Quality 
The Assessment of Multiple Systematic Reviews Tool (AMSTAR) is commonly 
used to determine the methodological quality of systematic reviews (Pieper et al., 2018). 
The following criteria are applicable to the methodological quality of a narrative 
systematic review (Shea et al., 2017): 
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(1) The research questions and inclusion criteria for the review include the components of 
PICO (Population, Intervention, Comparator and Outcomes). This includes specifying, for 
example, the demographics of the participants used in the studies, the type of treatments 
administered, the comparator groups used (such as healthy control participants or 
participants receiving placebo treatments), and the type of outcome (such as treatment 
outcome or assessment outcomes). (2) The report of the review contains an explicit 
statement that the review methods were established prior to conducting the review and any 
significant deviations from the protocol are justified. (3) The selection of the particular 
study designs for inclusion in the review is appropriately justified. (4) A comprehensive 
and exhaustive literature search strategy is used. (5) Study screening and selection is 
performed in duplicate. This requires each reviewer to select articles independently and 
blinded to ensure bias is minimised. Blinded selection entails that the selection made by 
one reviewer should be unknown to the other reviewer. (6) Data extraction is performed in 
duplicate. Each reviewer is required to extract data independently and blinded to ensure 
bias is minimised. (7) A list of excluded articles is available with reasons for exclusion. (8) 
The included studies are described in adequate detail as required to answer the review 
questions. (9) A satisfactory technique is used to assess the risk of bias (RoB) in individual 
studies that were included in the review. (10) The sources of funding for the individual 
studies included in the review are reported. (11) The RoB in individual studies is 
considered when interpreting or discussing the results of the review. (12) A satisfactory 
explanation for, and discussion of, any heterogeneity observed in the results of the review 
is provided. (13) If a quantitative synthesis was performed, an adequate investigation of 
publication bias (small study bias) is conducted and its likely impact on the results of the 
review is discussed. (14) Any potential sources of conflict of interest, including any 
funding received for conducting the review are disclosed. 
3.2.7 Review Types 
There are a number of different review types. The depth and breadth of 
investigation distinguish these review types from each other as illustrated in Figure 3.2. In 
this section breadth indicates the extent of the field of inquiry and depth is used to indicate 
the detail of inquiry which, in combination, constitute the scope of the review. For 
example, a review with the aim to provide a compendium of all psychometric assessments 
currently in use would be considered broad. In terms of depth, the detail of describing 
these assessment measures would be the determining factor. Technical aspects, such as 
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reliability, validity, normative data and standardisation methods would be considered more 
in-depth than a basic overview of the purpose of the measures.   
Heterogeneity refers to a high degree of diversity or difference in the content, 
specifically. For example, a sample of research articles could have high heterogeneity in 
terms of age: the age group of half of the studies is between 18 years and 25; and the age 
group of the other half is between 55 and 65. In this sense heterogeneity is a characteristic 
of the data. 
Figure 3.2 
Illustration of the Depth and Breadth of the Various Review Types 
 
As illustrated in Figure 3.2, the most in-depth and narrowly defined review type is a 
meta-analytical systematic review. Intuitively, the narrow area of investigation increases the 
likelihood of low data heterogeneity which, in turn, ensures a meta-analysis is possible. The 
broadest review type, with the primary aim of a general oversight, is the narrative review. 
The rapid review, scoping review, and systematic review with narrative synthesis can be 
heuristically categorised between these two extremes (Boland et al., 2017). An evidence 
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be described as the presentation of gaps in the research identified after synthesis (Miake-lye 
et al., 2016). 
Individual reviews, although categorised as a specific review type by virtue of 
fulfilling specific criteria, may also contain elements from other review types. This is 
represented in Figure 3.2 by the dotted rectangle. Table 3.1 provides a comparative 
breakdown of the main elements and criteria of each review type. 
Table 3.1 
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overview 
Narrative only Based on expert 
experience 
Timeframe Time-consuming Variable Variable Variable 






Note. Adapted from Doing a Systematic Review, by Boland et al., 2017, p. 42-43. 
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3.3 Methods 
3.3.1 Introduction 
In this section I describe the procedures followed in the current study. A general 
overview of the entire process is presented, which is followed by detailed explanations of 
each step in the process. 
3.3.2 Overview of Procedures 
The review conducted for the present study conforms to all the requirements of a 
systematic review as presented in Table 3.1. A predefined protocol (see Appendix A) was 
compiled with clearly defined research questions to address the main objectives of the 
systematic review. These are to identify the available empirical studies related to substance 
dependence and the neuropsychological assessment of executive functions and, by the use 
of appropriate methods, to analyse and synthesise the evidence in order to delineate the 
current body of knowledge and address the current state of fragmentation. Furthermore, an 
explicit methodology was followed which included a search strategy that was both 
sensitive and specific. Inclusion and exclusion criteria for the screening and selection of 
the search results were predefined and explicit. All stages of screening and selection, data 
extraction and quality assessment were done by two reviewers. The extracted data were 
highly heterogenous as anticipated and, therefore, a narrative synthesis was conducted. 
To ensure that the systematic review not only met the basic requirements of the 
methodology but also complied with quality criteria, the AMSTAR guidelines (Shea et al., 
2017) described earlier in this chapter were used throughout the course of conducting the 
research. 
The entire review process was conducted electronically. The software programme 
Mendeley (Elsevier, 2019) was used for reference management as it contains all the 
necessary features. These features include customisable organisation of options; automatic 
cloud storing and backup; use and synchronisation of data on numerous devices; and 
compatibility with other research information systems (RIS), such as Covidence (2019). 
The various software programs used for systematic reviews were considered (Columbia 
University Medical Center, 2018; Harvard Library, 2018; HLWIKI Canada contributors, 
2018). Thereafter, Covidence was chosen based on the following important features:  
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• Cochrane recommends using Covidence for all new reviews to streamline the most 
labour intensive stages of a systematic review (The Cochrane Collaboration, 2018). 
• Search results and documents can be easily imported. 
• User-friendly interface with high customisability to suit the requirements of the 
specific review being conducted. 
• The systematic review processes are streamlined  
• Comprehensive training and tutorial videos are freely available online. 
• More than one reviewer can work remotely on the systematic review. 
• All voting is blinded to ensure decisions are not biased. 
• All activities are recorded to ensure transparency. 
• The entire review process is tracked, recorded and stored. 
Data extraction and quality assessment was conducted using Google Forms. 
Although Covidence streamlined the screening and selection processes, the data extraction 
module of the software is primarily designed for intervention studies and only 
customisable to a limited degree. After a number of studies were piloted for data extraction 
on both Covidence and Google Forms, I decided that Google Forms would be more 
feasible for extracting data. 
3.3.3 Literature Search 
Two search methods were used in this systematic review. Citation chaining was 
conducted using existing systematic reviews and Boolean searches were carried out on 
both general and specialist electronic databases. 
3.3.3.1 Citation Chaining. 
Cribbin (2011) describes citation chaining as a method where citations within a 
seed article is searched to find articles that meet specific criteria. Snowballing can then be 
conducted, which entails performing the same citation chaining on the articles found from 
the seed article. Although citation chaining is not an explicit requirement for a systematic 
review it was conducted to ensure a higher likelihood that the relevant empirical studies 
would be included. The citation chaining process is presented in Figure 3.3. 
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Figure 3.3 
Flow Diagram of Citation Chaining Process 
 
Scoping searches were conducted on several databases for general reviews, 
systematic reviews and meta-analytic reviews using search terms related to the scope of 
the current systematic review (i.e., neuropsychological assessment, executive functions 
and substance dependence). Thirty-nine reviews were located. Of these reviews, 18 were 
excluded for not falling within the research scope. The 21 included reviews were citation 
chained as seed articles for additional reviews. Subsequently, snowball citation chaining 
was performed on the additional reviews. Twenty-seven reviews classified as systematic 
reviews or meta-analytic reviews were quality assessed using the AMSTAR criteria (Shea 
et al., 2017). Finally, 45 reviews were citation chained for empirical studies falling within 
the scope of this systematic review and a total of 1859 references were extracted. 
3.3.3.2 Electronic Database Searches. 
Three electronic databases, PubMed, PsycINFO and MEDLINE were used to 
search for published literature. These databases were selected as they were most likely to 
contain the relevant studies for the scope of the systematic review. A list of search terms 
was compiled after consultation with an information scientist, conducting scoping 
Scoping searches of databases for general reviews, 
systematic reviews and meta-analytic reviews  (n = 39)
Citation chained for additional reviews (n = 21)
Excluded (n = 18)
Reviews citation chained for empirical 
studies (n = 45)
Systematic reviews/meta-
analytical reviews quality 
assessed (n = 27) 
Articles extracted (n = 1859)
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searches, referring to related existing reviews and consulting relevant glossaries. Three 
comprehensive international glossaries were consulted for terms linked to substance 
dependence (Australian Drug Information Network, 2016; National Institute on Drug 
Abuse, 2016; The National Center on Addiction and Substance Abuse, 2017). The 
substances have several commercial and street names and these may vary from country to 
country. It is improbable that a study title and abstract will contain only the street name or 
commercial name of a substance. Therefore, only the most commonly recognised of these 
names were included in the search term list. All the internationally recognised terms for 
the substances were included in the list. These search terms were combined with terms 
related to executive functioning when conducting searches, considering both specificity 
and sensitivity of results. The search terms are listed in Table 3.2. 
Table 3.2 
Search Terms Used in MEDLINE, PubMed and PsycINFO 
Substance dependence  Executive functioning  
addiction  
drug dependence 
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A total of 494 searches were conducted during April and May 2019 using a 
Boolean strategy. All individual searches were timestamped and documented in detail. The 
results of each search were downloaded from the electronic database and saved in both a 
local drive and a cloud server for backup. The complete records of electronic database 
searches are publicly available at DOI: 10.13140/RG.2.2.35629.84964 
3.3.4 Screening and Selection  
As an overview, studies were included where the populations are humans 
presenting with substance dependence or substance use disorder and neuropsychological 
assessment of executive functions was administered. Studies with only animal models, 
neurocomputational models and other addictions were excluded (for example, gambling or 
internet gaming). Studies where instruments other than neuropsychological instruments 
were used exclusively, such as neuroimaging, biochemical or genetic methods, were also 
excluded. Studies were included with or without comparators (for example, the 
comparison between a treatment group and a control group; or the comparison between a 
treatment condition and a control condition). The measured outcomes of studies can be 
very different and therefore studies with any reported outcomes were included. These 
were, for example, related to adherence and relapse or the results of the 
neuropsychological assessment. With regard to study designs, publications with any study 
design were included with the one exception of qualitative designs. Studies that were 
conducted in any setting were included. These may be, for example, rehabilitation 
facilities, rural clinics, outpatient clinics, private practices and hospitals. 
Ethical violations were considered an exclusion criterion. This includes any form 
of harm, coercion, deception, breach of privacy and confidentiality, fabrications, omissions 
and contrivances (Wagner et al., 2012). However, none of the studies screened required 
exclusion on ethical grounds. Studies with null or negative findings are less likely to be 
submitted or selected for publication in peer-reviewed journals (Boland et al., 2017). To 
somewhat counteract this publication bias, studies from both peer-reviewed and non-peer-
reviewed journals were included. Finally, studies from any publication year and any 
language were included. 
The screening and selection process of the systematic review is presented in Figure 
3.4 using the PRISMA flow diagramme (Moher et al., 2009) and all the processes are 
described in detail in the sections that follow. In brief, a total of 16 265 references were 
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imported for screening from electronic database searches and reference chaining 
(described in more detail below).  
Table 3.3 
Inclusion and Exclusion Criteria 
Review Scope Executive functioning assessment of substance dependence 
individuals 
 Inclusion criteria Exclusion criteria 
Population Human population; 
Diagnosed with substance dependence; 
or diagnosed with substance use 
disorder 
Animal models excluding human 
population; 
Neurocomputational models 
excluding human population; 
Other addictions (gambling, 





measures of (a) executive functioning; or 
(b) general cognition with executive 
function as a subcomponent. Or (c) 
attention; or (d) working memory; or (e) 
decision making as subcomponents of 
executive functioning 
Neuroimaging, biochemical or 
genetic methods excluding 
neurocognitive assessment 
measures.  
Comparator All None 
Outcomes All None 
Study designs Randomised control trials 
Non-randomised control trials 
Cohort studies 
Case control studies 
Case series studies 
Cross-sectional studies 
Non-comparative studies 
Other (e.g. multi-method) 
Studies that are exclusively 
qualitative 
Setting All None 
Language All None 
Period All None 
Ethics Ethical conduct  Ethical violations* 
* Harm, coercion, deception, breach of privacy and confidentiality, fabrications, omissions and 
contrivances. 
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After 2 714 duplicates were removed, 13 551 titles and abstract were screened 
using the predefined inclusion and exclusion criteria as tabulated in Table 3.3. Following 
the exclusion of 12 778 studies, 695 full-text articles were assessed for eligibility. After the 
final exclusion of 305 full-text articles, data were extracted from 390 studies. 
Figure 3.4 
PRISMA Flow Diagramme of the Identification of Studies 
 
The electronic files containing the records of titles and abstracts (n = 16 265) from 
both the citation chaining and electronic database searches were uploaded to the systematic 
review software, Covidence. After duplicates were removed (n = 2714) the title and 
abstracts were screened for inclusion by two reviewers. This was done independently and 
blinded; in other words, information regarding the decisions of each reviewer was 
unavailable to the other reviewer. This ensures that bias is minimised by lowering the 
probability of following the decisions of the other reviewer as a shortcut. The second 
reviewer was selected from a number of undergraduate psychology students who 
16265 studies imported for screening 2714 duplicates removed
13551 studies screened 12778 studies irrelevant
695 full-text studies assessed for eligibility 
305 studies excluded 
 Reasons: 
 168 Methods 
 126 Population 
 11 Study design 
390 studies included
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volunteered their services and, besides having a special interest in neuropsychology, was 
also highly motivated and dedicated from the onset. 
All records were screened by me as first reviewer (n = 13 551) and a sample of 
records (n = 1117) was screened by the second reviewer. There was agreement between 
reviewers in 97.7 per cent of the records. Agreement was measured using Cohen’s kappa 
with a score of 0.89. The minimum required kappa score for sample screening is 0.8 (Shea 
et al., 2017). It was therefore concluded that screening criteria were sufficiently clearly 
specified to allow for adequate agreement between the two reviewers. The conflicts were 
resolved and the records that did not meet inclusion criteria were excluded (n = 12 778).  
The full-text articles for the included records were obtained electronically (where 
available – see below) and screened by two reviewers. Screening was done independently 
and blinded. All articles were screened by me (n = 695) and a sample of records (n = 271) 
was screened by the second reviewer. There was agreement between reviewers in 93.5 per 
cent of the articles. Agreement was measured using Cohen’s k. The agreement score was 
0.85 with the minimum required kappa score for sample screening being 0.8. The conflicts 
were resolved and the articles that did not meet inclusion criteria were excluded (n = 305). 
Full-text papers were electronically obtained through the university library. The 
library staff were contacted to assist with obtaining papers through the inter-library loan 
system in cases where the full-text papers were not available through the databases. A total 
of 97 articles were not available and these papers were also requested directly from the 
authors via email or online academic networking portals such as Researchgate. The same 
procedure was followed for papers that were published in languages other than English. Of 
the 773 included titles and abstracts, 68 full-text papers could not be located and 10 papers 
were published in foreign languages with no English versions available.  
The bibliography of the 390 included empirical studies is publicly available at 
DOI: 10.13140/RG.2.2.17030.73285/1 
The list of full-text articles that were not available for screening is publicly 
available at DOI: 10.13140/RG.2.2.14658.32962 
3.3.5 Data Extraction 
Pilot data extraction was performed on a number of studies using both the 
Covidence data extraction module and a custom designed data extraction form on Google 
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Forms (Table 3.4). Using Google Forms proved to streamline the process better than 
Covidence. Therefore, data extraction and quality assessment were subsequently 
conducted on Google Forms by both reviewers. Data extraction was done electronically by 
copying the relevant data from each electronic article and pasting it in the online data 
extraction form. This minimised the potential copying errors of paper data extraction. The 
extracted data were stored in a database located on both a local drive and a cloud server for 
backup. Because of the large number of studies included (n = 390), it was not feasible to 
conduct data extraction in duplicate when considering time constraints. Therefore, I 
conducted the majority of data extraction (n = 310) and randomly allocated a sample of 
articles (n = 80) to the second reviewer. The complete data tables are publicly available at 
the following URL: https://www.researchgate.net/publication/338479397_Data_Tables  
Table 3.4 
Data Extraction Form 
Heading Description of required data 
Title  Title of the publication 
Authors  Authors of the publication 
Country  Country where the research was conducted 
Setting Settings of participants during study (community, 
clinic, etc.) 
Study aims  The reported aims of the research 
Study design The study design of the research 
Theory of executive functions  The theory of executive functions used to support 
the research 
Funding and conflict of interest  Declaration of conflict of interest and list of 
funding sources 
Basic demographics of participants  Minimum of age, gender and education level 
Comorbidities  Any other medical conditions of participants 
Substance(s)  List of substances investigated in study 
SUD/dependence related diagnoses  Instruments used to diagnose substance abuse 
or dependence 
Inclusion criteria  Criteria used to include research participants  
Exclusion criteria  Criteria used to exclude research participants 
Group differences  How groups were defined in the study 
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Attrition  Any participants that were excluded or withdrew 
Interventions  Any experimental conditions assigned to the 
participants 
Neuropsychological assessment 
instruments of executive functioning  
List of neuropsychological instruments reported 
to assess executive functioning 
Findings - Neuropsychological assessment 
instruments of executive functioning  
The findings of neuropsychological instruments 
reported to assess executive functioning 
Other neuropsychological assessment 
instruments  
List of instruments reported to assess other 
neuropsychological domains 
Findings – Other neuropsychological 
assessment instruments 
The findings of instruments reported to assess 
other neuropsychological domains 
Study limitations  Reported limitations of the study 
 
3.3.6 Quality Assessment  
I conducted a pilot for data extraction and found it to be more feasible to perform 
quality assessment in conjunction with the data extraction and not as a completely separate 
process altogether. The main reason for this is because the reviewer is most familiar with 
each individual study directly after data extraction and therefore better able to make 
appropriate judgements, as opposed to a separate process of screening each article and then 
making judgements. 
The quality assessment entailed making judgements about the likelihood of 
potential risk of bias within each study. Because all study designs except qualitative 
designs were included in the systematic review, a customised assessment tool was 
designed. Various risk of bias tools were consulted to compile the assessment criteria 
(Critical Appraisal Skills Programme, 2018; Thomas et al., 2004; Zaza et al., 2000). The 
following items were included to assess the risk of bias of the included studies: (1) 
Selection bias was determined by evaluating if the participants in the study are 
representative of the target population and if appropriate recruitment methods were used to 
ensure this; (2) Attrition bias was determined by evaluating the drop-out or withdrawal rate 
of participants and if this was considered when data were analysed; (3) Data collection 
bias was determined by evaluating if the data collection instruments and methods were 
shown to be valid and reliable; (4) Reporting bias was determined by evaluating if all the 
outcomes stated to be measured were reported, even outcomes with null or negative 
findings; (5) Confounders was determined by evaluating if the participant characteristics 
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were matched or any other variables that may have a confounding effect; (6) 
Contamination or co-intervention was determined by evaluating if the participants 
received any unintended interventions or treatments; (7) Bias in analysis was determined 
by evaluating if the appropriate methods were used to analyse the data and all the data 
were reported; and (8) Funding bias was determined by evaluating if the any possible 
conflict of interests exist based on reported funding or affiliations. 
3.3.7 Data Analysis and Synthesis 
The raw data captured on the online data extraction form (Table. 3.4) were 
automatically stored on a secure online database. Upon completion of all data extraction, 
the raw data were downloaded in a tabulated format. Data analyses was done 
systematically in accordance with the research questions of the review. The data were 
somewhat inconsistent because, in addition to the large number of included articles, the 
articles originated from 121 different journals, 39 different countries and a publication date 
range of 34 years.  
The variation within the investigated categories had to be calculated through data 
analyses to reveal possible gaps and the extent of these gaps. Therefore, the index of 
qualitative variation (IQV) was used, where feasible, to calculated variability for nominal 
variables (Frankfort-Nachmias & Leon-Guerrero, 2009). This index ranges from no 
variation (0.00), where all the cases in the distribution are in one category, to maximum 
variation (1.00), where all the cases are distributed equally in all the possible categories 
(1.00). It is important to note that where the frequencies were calculated and data from a 
single study could be categorised into more than one category, the IQV would not be a 
valid measure of variability and was therefore not used. This is because the IQV reflects 
the variability of the differences between categories relative to the maximum possible 
differences in each distribution (Frankfort-Nachmias & Leon-Guerrero, 2009). 
3.3.7.1 Age. 
In the extracted data, entries for sample ages were variable; for example, the 
average age of each sample group or the combined average age of all sample groups. 
However, the entries with a combined average age of all sample groups excluded the 
healthy control groups. Therefore, this was the most detailed data that could be 
consistently validated across all entries and the data were coded to the average age of the 
combined sample groups (excluding healthy controls). The data could be further 
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categorised into age groups with intervals of five years, and the number and percentage of 
studies per age group was calculated. The IQV was used as a measure of variability. 
3.3.7.2 Education. 
Education data in some entries were explicit years, and in other entries more than 
or less than a number of completed educational years. The most detailed data that could be 
validated consistently across the dataset for education were categories of less than nine 
years (<9), between nine years and twelve years (9-12), and more than twelve years (>12). 
The data for education were coded to these categories, and the number and percentage of 
studies per educational-level category was calculated. The IQV was used as a measure of 
variability. 
3.3.7.3 Gender. 
The dataset for gender also contained high variability; for example, as a percentage 
or a ratio for specific sample groups or the combined sample groups (omitting number of 
participants per sample group in some studies). Therefore, the most detailed data that could 
be validated consistently across all data were categories of majority males (>50% males), 
majority females (>50% females), only females (100% females), only males (100% 
males), and equal females and males (50% females, 50% males). The number and 
percentage of studies per category was calculated. The IQV was used as a measure of 
variability. 
3.3.7.4 Substances. 
The data of substances were coded and each entry was categorised according to the 
investigated substance use disorder or substance dependence type. The IQV was used as a 
measure of variability. However, one third of the data entries investigated multiple 
substances and, therefore, it was necessary to determine the combined frequency of each 
substance category in all the data. Data coding was refined by listing all the investigated 
substances in all the data and determining the frequency of each substance. The number 
and percentage of each substance category was calculated.  
3.3.7.5 Comorbidities. 
All the possible comorbidities from the extracted data were coded and the 
following categories were compiled based on this list of comorbidities: 
psychosis/schizophrenia, human immunodeficiency virus (HIV), Korsakoff syndrome, 
attention deficit hyperactivity disorder (ADHD), mood disorders, personality disorders, 
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various psychiatric (multiple and variable diagnoses), Alzheimer’s disease/dementia, and 
other (single studies with conditions such as childhood trauma, homelessness, learning 
disabilities, liver cirrhosis, intellectual disability, mild traumatic brain injuries, 
neurocognitive disorders, obsessive-compulsive disorder, and viral infection). The number 
and percentage of studies per category was calculated.  
3.3.7.6 Substance Use and Dependence Criteria. 
The measurements to establish substance dependence in the data were coded. 
Because more than one measurement was used in some studies, the combined frequency of 
each measurement was calculated in all the data.  
3.3.7.7 Neuropsychological Assessment Instruments. 
The number and type of neuropsychological instruments varied significantly. 
Therefore, every assessment instrument in the data tables was coded and the combined 
frequency of each instrument in all the data was calculated. Individual instruments (or 
modules) were selected for administration from various assessment batteries in respective 
studies. However, it was necessary to determine the use of instruments most frequently 
used for the assessment of executive functions and therefore the frequencies of these 
individual instruments or modules were also calculated. These are tabulated in Table 3.5. 
Table 3.5 
Executive Function Assessment Instruments of Modules within Select Neuropsychological 
Assessment Batteries 
Neuropsychological Assessment Battery Executive function assessment 
instruments/modules 
Brief Assessment of Cognition in Schizophrenia 
(BACS) 
• Tower of London (TOLN) 
• Controlled Oral Word Association Test 
(COWAT) 
Behavioural Assessment of the Dysexecutive 
Syndrome (BADS) 
• Temporal Judgement (TJ) 
• Rule shift cards (RSC) 
• Action program (ACTP) 
• Key Search (KEY) 
• Zoo Map (ZOO) 
• Modified six elements (M6) 
• Dysexecutive questionnaire (DEX) 
Delis-Kaplan Executive Function System 
(D-KEFS) 
• Twenty questions test (DKEFS-20) 
• Color-Word Interference Test (DKEFS-
CW) 
• Design Fluency (DKEFS-D) 
• Proverbs test (DKEFS-P) 
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• Sorting test (DKEFS-S) 
• Tower Test (DKEFS-T) 
• Trail Making Test (DKEFS-TMT) 
• Verbal Fluency (DKEFS-VF) 
Cambridge Neuropsychological Test Automated 
Battery (CANTAB) 
• Cambridge Gambling Task (CGT) 
• Intra/Extra Dimensional Set Shift (IED) 
• Multitasking Test (MTT) 
• One-Touch Stockings of Cambridge 
(OTS) 
• Spatial working memory (SWM) 
• Stockings of Cambridge (SOC) 
• Stop Signal Task (SST) 
 
3.3.7.8 Theories of Executive Functioning. 
All the possible constructs used to describe or define executive functioning in the 
data tables were coded and the frequency of use of each construct was calculated.  
3.3.7.9 Settings. 
The data for settings were coded and categorised into treatment facilities (not 
specified), inpatient, outpatient, day clinic, correctional facility, community (no treatment 
specified), and various categories with a combination of the latter. Thereafter, the total 
number and percentage of studies for each setting category was calculated. The IQV was 
used as a measure of variability. 
3.3.7.10 Countries. 
The country that each study was conducted in was coded and the frequency was 
calculated. The countries were also categorised into the major global regions, namely 
Africa; Asia; Europe; Latin America and the Caribbean; North America; Oceania; and 
International and the percentage of studies per region was calculated. The IQV was used as 
a measure of variability. 
3.3.7.11 Study Designs 
The primary study design used in each study was coded, and the frequency and 
percentage of each study design was calculated. The IQV was used as a measure of 
variability. 
3.3.7.12 Comparators. 
Because of the high variability in comparator data, it was not possible to code each 
datum into a distinctive category. Instead, the frequency of use of the each coded 
comparator in all the data was calculated. The comparator categories were: (1) healthy 
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control group; (2) different substance group; (3) different use group; (4) different exposure 
history group; (5) control intervention/placebo group; and (6) different outcome group. 
The frequency was calculated of each of the latter categories. 
3.3.7.13 Risk of Bias. 
There were eight categories for risk of bias, namely selection bias; attrition bias; 
data collection bias; reporting bias; confounders; contamination or co-intervention; bias in 
analysis; and funding bias. For each category of each study the data entry options were 
low, high or unclear/unknown. The total number of each data entry for each category was 
calculated. Thereafter, the percentage of each data entry for each category was calculated. 
3.3.7.14 Findings. 
The high baseline and design-related heterogeneity of the included studies made it 
unfeasible to combine the statistical results through meta-analysis. Therefore, the study 
results were analysed by coding and categorising the results related to the relationship 
between executive functions and substance dependence in the extracted data of the 
respective studies. The results were considered either a reported causality or correlation 
between the variables. These were categorised as (1) a relationship between lower 
executive functioning scores and substance disorders; (2) a relationship between higher 
executive functioning scores and substance dependence; (3) no relationship between 
executive functioning scores and substance dependence; (4) mixed or inconclusive 
findings; and (5) other (individual studies with no explicit results for an executive 
functioning and substance dependence relationship). The total number and percentage of 
each findings category was calculated. 
3.3.7.15 Cross-tabulation. 
The study design categories and substance categories were cross-tabulated to 
determine the number and percentage of each study design per substance category; the 
substance categories and findings categories were cross tabulated to determine the number 
and percentage of each findings category per substance category; and, the findings 
categories were cross-tabulated with the study design categories to determine the number 
and percentage of each findings category per study design category. 
3.3.8 Ethical Considerations 
Ethical approval for the systematic review was obtained from the UNISA 
Department of Psychology College of Human Science Ethics Committee (Appendix B). 
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The ethical considerations of each included study of the proposed review was considered 
during quality assessment and data analysis. These included any form of harm, coercion, 
deception, breach of privacy and confidentiality, fabrications, omissions and contrivances. 
To the best of that which could be ascertained only research studies conducted ethically 
were included in this review. 
This study was partially funded by the Student Funding Directorate of the 
University of South Africa. The author declares that the research was conducted in the 
absence of any commercial or financial relationships that could be construed as a potential 
conflict of interest. 
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Chapter 4: Results 
4.1 Introduction 
As described in the previous chapter, 390 studies were identified that met all of the 
criteria for inclusion, namely the assessment of executive functioning in substance 
dependence populations using neuropsychological instruments. In this chapter, I present 
the findings that answer the research questions, as formulated in the protocol (see 
Appendix A). These findings include the demographics and other characteristics of the 
population samples within the research studies; the methods for diagnostic and 
neuropsychological assessment; the general study characteristics such as study designs, 
settings and countries; and finally, the results from the research studies pertaining to 
executive functioning and substance dependence.  
4.2 Publication Characteristics of Included Articles 
Figure 4.1 
Number of Published Articles per Year (1985-2019) 
 
To somewhat address publication bias, as proposed in the protocol, there was no 
restriction for including studies from non-peer-reviewed journals. Notwithstanding, after 
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analysis it was established that all the included articles were published in peer-reviewed 
journals. There was also no restriction for publication years. The date range for the 
included studies is 1985 to 2019 and Figure 4.1 illustrates the trend of studies published 
per year. The graph shows the number of published articles have increased over the years 
and especially between 2000 and 2019. It should be noted that the literature search was 
conducted in May 2019 and, therefore, the actual number of articles for 2019 is likely to be 
higher. 
4.3 Demographics of Samples  
Because of the high heterogeneity of the research studies, the reporting of sample 
ages also differs considerably in terms of the comparator groups and study designs. In each 
study, however, the groups were matched. Therefore, the data of all the groups in each 
study were combined and the mean value was used for age and education, whereas 
percentage was used for gender. In longitudinal studies, the values reported with first 
assessment was used. One study followed samples from birth and another from age five 
with multiple assessments throughout lifetime. For these two outliers, age and education 
were categorised as not applicable.  
4.3.1 Age 
Figure 4.2 
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The mean age of the combined sample groups in each study was used to determine 
the percentage of studies per age group presented in Figure 4.2. Seventy per cent of all 
studies (n=273) had a mid-adulthood sample age, ranging between 30 and 50 years. Only 
3.8 per cent of studies had a sample consisting of adolescents, younger than 20 years 
(n=15). Fourteen per cent had a sample of early-adulthood, 20 to 30 years (n=55) and 9.3 
per cent for senior-adulthood, older than 50 years (n=39). The index of qualitative 
variation (IQV) (Frankfort-Nachmias & Leon-Guerrero, 2009) was used to establish the 
variability in the distribution of sample ages. An unequal distribution on the age-group 
categories was revealed by a variability of 0.92.  
4.3.2 Education 
Figure 4.3 
Percentage of Research Studies per Education Level 
 
The mean education level of the combined sample groups in each study was used 
to determine the percentage of studies per education category (years of education) 
presented in Figure 4.3. Almost half of the studies (47.3%) had samples with an 
educational level of more than 12 years (n=184) and 34.9 per cent had samples that 
completed some level of secondary education (n=136). Forty-six studies (11.8%) did not 
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used to calculate the variability of 0.80 which revealed an uneven distribution on the 
categories for education. 
4.3.3 Gender 
The gender proportion (percentage of individuals per gender) of the combined 
sample groups in each study was used to determine the percentage of studies per gender 
proportion category presented in Figure 4.4. Seventy-nine per cent of the studies had a 
combined sample consisting of more males than females (n=308). Of these studies, 67 
(17.2%) was categorised as having exclusively-male samples and 241 studies (61.8%) was 
categorised as having majority-male samples. Only 59 studies had samples containing 
females, with seven exclusively female. Twenty-three studies (5.9%) did not report on the 
genders of samples. A variability score of 0.69 revealed a significant unequal distribution 
on the gender proportion categories as determined by the index of qualitative variation. 
Figure 4.4 
Percentage of Research Studies per Gender Proportion Category 
 
4.3.4 Substances 
The research studies were categorised according to the specific substance disorders 
of each study and Figure 4.5 illustrates the percentage of studies per category. One third of 
the studies (n=130) investigated multiple substance-disorders followed by 28.2 per cent 
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benzodiazepine (n=2), ketamine (n=2), amphetamine (n=1), and MDMA (n=1), 
exclusively. The variability of the distribution of 0.85 was calculated using the index of 
qualitative variation and revealed an unequal distribution on the substance disorder 
categories. 
Figure 4.5 
Percentage of Studies per Substance Disorder 
 
Because of the large number of studies investigating multiple substance-disorders 
and some with polysubstance disorders, it was necessary to also establish the frequency of 
investigation of each substance. Additionally, in cases where classes of substances were 
investigated and the individual substances not explicitly specified, the substance class was 
used. This provides the total number of studies per substance or category; or the total 
number of each substance dependent population. The findings from this analysis are 
presented in Figure 4.6. 
When the frequency of each substance or class of substance was calculated it was 
revealed that alcohol remained the most investigated with 57.4 per cent of the studies or 
224 population samples. There are studies with sub-samples of benzodiazepine (n=10), 
ketamine (n=7), amphetamine (n=14) and MDMA (n=12) which increases the small 
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studies investigating cannabis increased to 85 in contrast to only 18 for cannabis 
exclusively.  
Figure 4.6 
The Number of Population Samples for Each Substance or Class of Substances 
 
Note. NOS = Not otherwise specified. MDMA = 3,4-Methylenedioxymethamphetamine. 
GHB = gamma-hydroxybutyrate. 
 
4.3.5 Comorbidities 
There were 89 research studies that investigated specific comorbidities in 
conjunction with the substance disorders. The number of studies for the various 
comorbidities is illustrated in Figure 4.7. These studies had either substance dependent 
sample groups with comorbid conditions or substance dependent comparison groups with 
these conditions. Psychosis/schizophrenia (n=21), human immunodeficiency virus (n=18) 
and Korsakoff syndrome (n=14) were the main conditions investigated. The Other 
category included single studies with comorbid childhood trauma, homelessness, learning 
disabilities, liver cirrhosis, intellectual disability, mild traumatic brain injuries, 
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Figure 4.7 
Number of Studies Investigating Comorbidities 
 
4.4 Assessment Instruments and Criteria Used in Studies 
4.4.1 Substance Use and Dependence Criteria 
Thirty-six different criteria were used to determine substance use and dependence 
in the research studies. These included formal assessment measures and self-report 
questionnaires. Because a proportion of studies used more than one measure the frequency 
of use had to be established. These frequencies are graphed in Figure 4.8 with measures 
used less than four times combined in the Other category. The Diagnostic and Statistical 
Manual of Mental Disorders, fourth edition (DSM-IV) criteria were used in 205 research 
studies, accounting for 52.6 per cent of all the studies. Seventy-three per cent of the studies 
(n=285) used the DSM criteria in general (editions III, III-R, IV, IV-TR, or V). In 
comparison, the criteria of the International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision (ICD-10) was used in only 26 studies (6.7%). 
Although many of the measures and criteria rely on self-reporting, twenty three studies 
used self-reporting as a method to determine substance use without specifying the structure 
of this measure. Twenty-four studies (6%) did not report on the substance-related criteria 
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Figure 4.8 
Substance Use and Dependence Criteria Frequency of Use 
 
Note. DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, fourth edition. 
DSM-IV-TR = Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text 
revision. ICD-10 = International Statistical Classification of Diseases and Related Health 
Problems, 10th revision. DSM-III-R = Diagnostic and Statistical Manual of Mental 
Disorders, third edition, revised. DSM-5 = Diagnostic and Statistical Manual of Mental 
Disorders, fifth edition. FAGERT = Fagerström test of nicotine dependence. AUDIT = 
Alcohol Use Disorders Identification Test. ASI = Addiction Severity Index. IRAB = 
Interview for Research on Addictive Behavior. SDS = Severity of Dependence Scale. 
4.4.2 Neuropsychological Assessment Instruments 
A total of 248 neuropsychological assessment instruments and batteries were used 
in the 390 research studies. Because the number and combination of assessment 
instruments varies from one study to the next it was necessary to determine the frequency 
of use for each instrument in all the studies. The assessment instruments used more than 14 
times are graphed in Figure 4.9. The assessment batteries for general cognition are not 
included in the graph; however, the comprehensive table of all neuropsychological 
assessment instruments is publicly available at DOI: 10.13140/RG.2.2.11997.56800/1. The 
assessments that were used most frequently were the Wisconsin Card Sorting Test (n=175, 
45.9%), the Trail Making Test Part B (n=167, 42.8%), the Stroop Test (n=146, 37.4%) and 
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Figure 4.9 
Most Frequently Used Neuropsychological Assessment Instruments 
 
Note. WCST = Wisconsin Card Sorting Test-64. TMT-B = Trail Making Test part B. 
Stroop = Stroop Color-Word Test. TMT-A = Trail Making Test part A. COWAT = 
Controlled Oral Word Association Test. IGT = Iowa Gambling task. ROCFT = Rey–
Osterrieth Complex Figure Test. GPB = Grooved Peg Board. FAS = FAS Verbal fluency. 
RAVL = Rey Auditory Verbal Learning Test. VF-NS = Verbal Fluency (not specified). 
CVLT = California Verbal Learning Test. CPT = Continuous performance task. BVMT-R 
= Brief Visuospatial Memory Test—Revised. VF-CAT = Verbal Fluency Category Test. 
GONO = Go/No Go task. N-Back = N-Back continuous performance task (including 2-
back version). SDMT = Symbol Digits Modalities Test. CVLT-II = California Verbal 
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Dimensional Set Shift (CANTAB) = BVRT = Benton Visual Retention Test. BIS = Barratt 
Impulsiveness Scale. TOLN = Tower of London. HVLT-R = Hopkins Verbal Learning 
Test—Revised. FAB = Frontal Assessment Battery. 
4.5 General Characteristics of Studies 
4.5.1 Theories of Executive Functions 
The extracted data were analysed to distinguish studies that used a theory or 
description of executive functioning from studies that did not. The percentage of studies 
that used a theoretical description of executive functioning was 35.6 per cent (n=139).  
Figure 4.10 
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Note: The constructs and frequency of use presented in this graph has been extracted only 
from studies providing a theory or description of executive functioning (n=139). 
All the constructs used to describe executive functioning were extracted from the 
data tables and the frequency of use was calculated. A total of 36 constructs were 
extracted. Figure 4.10 presents the frequency with which each construct was used in all the 
studies that provided a description. The construct inhibition or its inverse, impulsivity, was 
used most often as a component to describe executive functioning (n=74, 53.2%). This is 
followed by planning, cognitive flexibility, and working memory which were used in 40 
per cent of the studies. 
4.5.2 Settings 
The dataset for settings was obtained from the recruitment procedures of 
population samples, excluding healthy controls. As presented in Figure 4.11, the majority 
of studies (68.7%, n=268) had population samples from a treatment facility setting.  
Figure 4.11 
Percentage of Studies per Setting Category 
 
These included residential or hospitalised inpatients, outpatients with routine visits, 
day clinics where patients spent each evening at home, a combination with samples drawn 
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using the index of qualitative variation, was 0.89 and revealed an unequal distribution on 
the categories for settings. 
Eighty-eight studies (22.6%) drew samples from the community, including 
correctional facilities, which comprises individuals not explicitly reported as receiving 
treatment. There were also studies that recruited samples from both community and 
treatment settings (n=13). Twenty-one studies (5.4%) did not report recruitment 
procedures of samples; therefore, the settings for these studies could not be established. 
4.5.3 Countries 
As presented in Figure 4.12, the research studies were conducted in thirty-eight 
countries and one international study where population samples were recruited and 
participated via the internet. The largest number of studies (42.6%, n=166) originate from 
the United States of America, followed by Spain (8.7%, n=34), Germany (5.4%, n=21) and 
Brazil (5.1%, n=20). The countries were further categorised according to global region and 
this revealed that 46 per cent of the studies originate from North America, 32 per cent from 
Europe, 12 per cent from Asia and a minority from Oceania, Latin America and the 
Caribbean. There were no studies originating from Africa. The index of qualitative 
variation was used to calculate the variability score of 0.82. This revealed an unequal 
distribution between countries with research studies. 
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Figure 4.12 
The Number of Studies per Country and Percentage of Studies per Global Region 
 
4.5.4 Study Designs  
Twenty-eight (7.2%) of the research studies were experimental, which included an 
intervention as part of the study design; and the majority, 362 (92.8%), were observational. 
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studies (n=291) had a cross-sectional design, primarily reporting on findings from a 
specific point in time. Sixty-nine studies had a cohort design, with studies observing 
changes over time either retrospectively (n=8) or prospectively (n=61). There were only 
two case studies. The variability score of 0.5 revealed a significant unequal distribution on 
the study design categories as calculated using the index of qualitative variation. 
Figure 4.13 
Percentage of Studies per Study Design 
 
4.5.5 Comparators 
Healthy control groups were used in a large proportion of the studies (n=256, 
65.6%). Control intervention or placebo groups were used in 28 studies (7.2%) and 
outcome groups in 89 studies (22.8%). Forty-four studies (11.3%) compared groups using 
different substances and 49 studies (12.6%) compared groups with differences in use. A 
small number of studies (n=8; 2%) compared groups in terms of exposure history. These 
results are presented in Figure 4.14. 
There were ninety-two studies with additional atypical comparison groups that 
were combined as Other. These included various comparator groups that fall into different 
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Figure 4.14 
Frequency of the Use of Various Comparators in the Research Studies 
 
4.5.6 Study Designs in Terms of Substances 
The substance categories were cross-tabulated with the various study designs. From 
this it is evident that the majority of studies for all substance categories had a cross-
sectional design. The only two case studies were for cannabis. There were no studies with 
a prospective or retrospective cohort design for opiates and only one study with a 
retrospective cohort design for heroin. These are presented in Figure 4.15 and the number 
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Figure 4.15 
Proportion of Study Designs Used for Each Substance Category 
 
Table 4.1 
Number and Percentage of Studies According to Study Design and Substance Category 












Alcohol 81 20.77 % - - 3 0.77 % 20 5.13 % 4 1.03 % 2 0.51 % 
Amphetamine 1 0.26 % - - - - - - - - - - 
Benzodiazepine 1 0.26 % - - - - 1 0.26 % - - - - 
Cannabis 10 2.56 % 2 0.51 % 0 
 
5 20.77 % 1 0.26 % - - 
Cocaine 31 7.95 % - - 4 1.03 % 8 2.05 % - - 1 0.26 % 
Heroin 8 2.05 % - - - - - - - - 1 0.26 % 
Ketamine 2 0.51 % - - - - - - - - - - 
MDMA 1 0.26 % - - - - - - - - - - 
Meth-
amphetamine 
22 5.64 % - - - - 3 0.77 % 1 0.26 % 1 0.26 % 
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Nicotine 15 3.85 % - - 2 0.51 % 5 1.28 % 2 0.51 % - - 
Opiate 9 2.31 % - - - - - - 1 0.26 % - - 
Polysubstance 10 2.56 % - - - - 1 0.26 % - - 1 0.26 % 
 
4.5.7 Risk of Bias and Limitations 
These results should be interpreted with caution as many of the judgments could be 
construed as a study limitation instead of a risk of bias. Therefore, it can be surmised that 
the risk of bias has been overestimated. A further discussion follows in Chapter 5. Even 
with an overestimation, the overall risk of bias of the research studies was low for all risk 
of bias types.  
As presented in Figure 4.16, the risk of selection bias for the majority of research 
studies was low (n=322; 82.6%) compared to 61 studies (15.6%) judged as having a high 
risk. Eighty-six per cent (n=336) of the studies had a low risk of attrition bias in 
comparison to 9.2 per cent (n=36) with a high risk judgement. Sixty-two studies (15.9%) 
had a high risk of data collection bias and 320 (82.1%) had a low risk. A small number of 
studies had a high risk of reporting bias (n=13; 3.3%) and 364 studies (93.3%) had a low 
risk. The risk of confounder bias and contamination bias was judged high in a substantial 
number of studies. Confounder bias was judged as high in 128 studies (32.8%) and 250 
studies (64.1%) were judged as low. The risk of contamination bias judgement was high in 
145 studies (37.2%) and low in 210 studies (53.8%). Bias in analysis was low in 364 
studies (93.3%) and high in 12 studies (3.1%). The number of studies were substantial 
(n=63; 16.2%) that did not report on funding or required more information to determine 
the risk of funding bias. 
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Figure 4.16 
Synthesised Ratings for the Research Studies per Risk of Bias Type 
 
4.6 Findings of Studies 
In terms of all the study and population characteristics presented thus far, it was 
anticipated that the reported results of the studies would also be highly heterogeneous. 
Therefore, the study results were analysed by locating the findings related to the 
relationship between executive functions and substance disorders in the extracted data of 
the respective studies and categorising these findings.  
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Figure 4.17 
The Percentage of Studies per Findings of the Relationship between Executive Functioning 
and Substance Dependence or Disorders 
 
Note. EF = Executive functioning. SD = Substance disorders/dependence. 
The findings were categorised as reporting (1) a relationship between lower 
executive functioning scores and substance disorders (n=261, 66.9%); (2) a relationship 
between higher executive functioning scores and substance dependence (n=3, 0.8%); (3) 
no relationship between executive functioning scores and substance dependence (n=25, 
6.4%); (4) mixed or inconclusive findings (n=46, 11.8%); and (5) other (n=55, 14.1%) 
which are included in the categories listed in Table 4.2. These categories are graphed in 
Figure 4.17. It is important to note that the categories refer specifically to executive 
functioning scores and not executive functioning abilities. This is to take into consideration 
the high variability in both the constructs used to define executive functioning (see Section 
4.5.1) and the different assessment instruments used to measure these constructs (see 
Section 4.4.2). 
The number of studies with other or additional findings are listed in Table 4.2. 
Thirty-six studies had findings about differences in neurophysiological morphometry or 
neurobiological markers related to executive functioning and substance dependence. The 
treatment group (where treatment was investigated) executive functioning scores was 
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score in the treatment group. Two reported no differences and one reported lower scores in 
the treatment group.  
Table 4.2 
Number of Studies with Other and Additional Findings Related to Executive Functioning 
and Substance Disorders 
Variables  Number of studies 
Neurophysiology/neurobiology  36 
Treatment group 22 
Abstinence 18 
Severity of use (general) 15 
Comorbidity 11 
Different substance type groups 9 
Years of use 8 
Treatment outcome 7 
Early onset 5 
Methadone maintenance 5 
Neuropsychological instrument properties 5 
Poor treatment outcome 5 
Relapse group 5 
Denial/Motivation/other trait 4 
Personality disorders 4 
Social cognition 4 
Treatment drop-out 3 
Abstinence (early) 2 
Different methods of use 2 
Emotional regulation 2 
Gender differences 2 
Specific neuropsychological instrument results 2 
Adverse withdrawal 1 
Chemical and behaviour 1 
Childhood factors 1 
Multiple confounders 1 
Parental exposure 1 
Polysubstance 1 
Severity of use (dosage) 1 
Severity of use (route of administration) 1 
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Seven studies had findings related to treatment outcome (where outcome was 
investigated) of which three reported executive functioning scores did not predict 
treatment outcome, one that executive functioning scores predicted treatment outcome, 
two reported a relationship between lower executive functioning scores and poorer 
treatment outcome and one reported no relationship was found between executive 
functioning scores and treatment outcome. 
Eighteen studies had findings related to abstinence. Of these, eight reported on a 
relationship between abstinence and higher executive functioning scores; nine reported no 
relationship and one study had mixed results. There were also two studies that reported on 
early abstinence specifically, with both reporting a relationship between early abstinence 
and lower executive functioning scores. Findings related to the severity of substance use 
and executive functioning was reported in 17 studies, one of which provided results on the 
substance dosage and another on the substance route of administration. Sixteen of these 
studies reported lower executive functioning scores with an increased severity of use and 
one reported higher anhedonia with an increased severity of use.  
Of the five studies that had findings related to methadone maintenance, three 
reported a relationship between methadone maintenance and lower executive functioning 
scores, one reported higher scores and one reported scores within the normal range. 
In terms of the years of education and findings, there were only 22 studies with 
samples that had an educational level of less than nine years. Of note, however, is that 77 
per cent of these studies (n=17) reported lower executive functioning scores in substance 
dependent samples; in comparison to 71 per cent (n=97) of the studies with participants 
who had completed some secondary education; and 63 per cent (n=117) of the studies with 
participants who had 12 years of education or more. 
4.6.1 Findings of Studies in Terms of Study Designs 
The findings and study designs were cross-tabulated and Figure 4.18 presents the 
proportion of findings for the various study designs. The majority of the studies with a 
cross-sectional design reported a relationship between lower executive function scores and 
substance dependence (n=212). However, a substantial number of cross-sectional studies 
had mixed or inconclusive results (n=36) and two reported a relationship between 
substance dependence and higher executive function scores. The studies with prospective 
cohort designs also had a majority of studies reporting a relationship between lower 
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executive function scores and substance dependence. The randomised and non-randomised 
controlled trials had mostly findings related to different treatment types and was 
categorised as other. Table 4.3 contains the number of studies for each study design and 
different findings. 
Figure 4.18 
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Table 4.3 

















Lower EF and 
SD 
212 54.36 % 2 0.51 % 3 0.77 % 39 10 % 1 0.26 % 4 1.03 % 
Higher EF and 
SD 
2 0.51 % - - - - 1 0.26 % - - - - 
No relationship 
EF and SD 
22 5.64 % - - - - 2 0.51 % 1 0.26 % - - 
Mixed/ 
Inconclusive 
36 9.23 % - - 1 0.26 % 7 1.79 % 1 0.26 % 1 0.26 % 
Other  19 4.87 % - - 9 2.31 % 12 3.08 % 12 3.08 % 3 0.77 % 
Note. EF = Executive functioning. SD = Substance disorders/dependence. 
4.6.2 Findings of Studies in Terms of Substances 
The substance categories and findings were cross-tabulated and the results are 
presented in Figure 4.19. Eighty-two of the studies investigating alcohol reported a 
relationship between lower executive functioning scores and substance dependence. Eight 
studies had mixed or inconclusive results and six reported no relationship could be found 
between executive functioning scores and substance dependence. For nicotine, seven 
studies reported a relationship between lower executive functioning scores and substance 
dependence, three had mixed results, five found no relationship and one reported higher 
executive functioning scores with substance dependence. The number of studies for each 
substance and findings category is listed in Table 4.4. 
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Figure 4.19 
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Number and Percentage of Studies for Each Substance Category and Findings 
 
Alcohol Amphetamine Benzodiazepine Cannabis Cocaine Heroin Ketamine 
Higher EF and SD - - - - - - 1 0.26 % - - - - - - 
Mixed/ Inconclusive 8 2.05 % 1 0.26 % - - 2 0.51 % 4 1.03 % 3 0.77 % 1 2.05 % 
No relationship EF 
and SD 
6 1.54 % - - - - 2 0.51 % 2 0.51 % - - - - 
Lower EF and SD 82 21.03 % - - 2 0.51 % 9 2.31 % 30 7.69 % 5 1.28 % 1 0.26 % 
Other  14 3.59 % - - - - 4 1.03 % 8 2.05 % 1 0.26 % - - 
 
Methamphetamine MDMA Multiple Nicotine Opiate Polysubstance 
  




Mixed/ Inconclusive 1 0.26 % - - 20 5.13 % 3 0.77 % 1 0.26 % 2 0.51 % 
  
No relationship EF 
and SD 
1 0.26 % - - 8 2.05 % 5 1.28 % - - 1 0.26 % 
  
Lower EF and SD 21 5.38 % 1 0.26 % 86 22.05 % 7 1.79 % 8 2.05 % 9 2.31 % 
  
Other  4 1.03 % - - 15 3.85 % 8 2.05 % 1 0.26 % - -   
 
Note. EF = Executive functioning. SD = Substance disorders/dependence. 
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4.7 Conclusion 
In this chapter the findings of the systematic review were presented after 
synthesising the data from all the included research studies. The demographics of the 
population samples were depicted by providing an overview of the distribution and 
variation in terms of age groups, educational level, gender distribution, substance 
dependence and comorbidities. The various criteria used to determine substance use and 
dependence were described, as well as the numerous neuropsychological instruments to 
assess executive functioning. In terms of study characteristics, I presented the multitude of 
constructs used to define or describe executive functioning, the settings, the countries, the 
various study designs, and the different comparator sample groups used in the studies. 
Furthermore, the results from the risk of bias assessment of the research studies were 
delineated. Finally the results of the research studies related to executive functioning and 
substance dependence were synthesised. These synthesised findings were presented for all 
the studies, the various substance categories and the different study designs. The 
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Chapter 5: Discussion and Conclusions 
5.1 Introduction 
The main objectives of this systematic review were to identify the available 
empirical studies related to substance dependence and the neuropsychological assessment 
of executive functions, and to conduct a synthesis with the aim of delineating the current 
state of the existing body of knowledge and addressing the current state of fragmentation. 
To accomplish this, the following predefined review questions had to be answered: (1) 
Which substance dependent populations have been assessed using neuropsychological 
measures for executive functioning? (2) Which assessments and batteries were used to 
measure executive functioning? (3) What comparators were used in the respective studies? 
(4) What are the findings of the neuropsychological assessment measures? (5) In what 
settings were assessments conducted? (6) Which study designs were used? (7) What is the 
risk of bias within the respective studies? (8) What are the key consensus or near-
consensus findings regarding the relationship between executive functions and substance 
dependence? (9) Are there any marked differences or inconsistencies between studies? 
(10) What are the strengths and limitations of the study designs that were used? (11) Are 
there any controversial issues? (12) Is exhaustive evidence provided or are there gaps and 
a need for further research? 
In this chapter these questions are answered by discussing the results presented in 
Chapter 4. The main findings of the systematic review are discussed in terms of the 
demographics, substances, neuropsychological assessment measures, diagnostic criteria, 
study characteristics (theories, study designs, settings and countries) and findings. 
Thereafter, the strengths and limitations of the systematic review are discussed. Lastly, the 
identified gaps and implications of the findings are outlined, and a conclusion is provided. 
5.2 Main Findings 
5.2.1 Demographics 
There were very few studies of adolescents and senior adults as most of the studies 
had samples aged between 30 and 50 years. Contrary to the latter, the observed trends for 
peak levels of substance use in most international regions and for most substances are 
observed among individuals aged between 18 and 25 years (United Nations Office on 
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Drugs and Crime, 2019). The majority of studies had samples with either completed or 
partially completed secondary education and only a small number of studies had samples 
with an education of less than nine years. In terms of the gender distribution of the studies, 
these are significantly uneven with the largest number of studies having a majority of 
males within the population samples. The uneven distribution of sample demographics of 
the included studies might be because of an uneven distribution existing in the various 
populations (United Nations Office on Drugs and Crime, 2017, 2019); however, it may 
also be because of various types of sampling bias (Wagner et al., 2012). The highly unique 
challenges faced by women with substance dependence, especially the various barriers to 
treatment access and a number of other social factors outlined by Tuchman (2010), should 
also be considered as possible reasons for the significant unequal distribution of gender in 
the samples of research studies. Furthermore, gender differences in terms of executive 
functioning and substance dependence are important because differences between the 
sexes in terms of neurophysiology and neurodevelopment have been demonstrated. 
Although, in general, the group differences in overall neuropsychological performance are 
less than half of a standard deviation (Mitrushina et al., 2005), fragmentation exists for 
specific domains such as executive functioning. Only a select number of the included 
studies investigated gender differences and this is clearly a significant weakness in the 
existing body of knowledge. 
5.2.2 Substances 
When the studies were categorised per substance, one third of the studies 
investigated multiple substances which included samples using different substances. This 
is followed closely by alcohol. In terms of the number of substance samples within all the 
included studies, more than half of all the studies had alcohol dependent samples and a 
third had samples with cocaine disorders. Compared to the few studies investigating 
cannabis exclusively, there were more studies with cannabis dependent sub-groups. There 
were very few studies investigating the effects of dependence to amphetamine, 
benzodiazepine, heroine/opiates and ketamine on executive functioning, exclusively. This 
suggests that relatively little research has been done on the link between substance 
dependence and executive functioning for substances other than alcohol, cannabis and 
cocaine. 
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5.2.3 Neuropsychological Assessment Measures 
The Wisconsin Card Sorting Test (WCST), the Trail Making Test (TMT) and the 
Stroop Test were the most used instruments for executive functioning assessment. Overall, 
the frequency of instrument usage in the research studies corresponds to the reported 
assessment practices in neuropsychology (Rabin et al., 2005; Rabin et al., 2016; Strauss et 
al., 2006). The WCST is the most used instrument for executive functioning in these 
findings as well as in more general reported test-usage. The TMT and Stroop Test are also 
ranked within the top five of these reports. However, there are some noteworthy 
differences: The Delis–Kaplan Executive Function System (D-KEFS) is a useful battery 
for isolating and revealing underlying neurocognitive mechanisms and thereby reducing 
the persistent task impurity problem in neuropsychological assessment (Delis et al., 2004; 
Strauss et al., 2006). This battery was used in only twelve studies of the current systematic 
review and only a select number of modules of the battery was used; this contrasts with the 
latest report by Rabin et al. (2016) which ranks the use of this battery among the top five. 
Similarly, the Halstead Category Test is used in only eight studies, but is ranked among 
the top ten in the reported assessment practices. This test measures abstraction, concept 
formation, flexibility, novel problem solving and the ability to learn from experience. It is, 
therefore, evident why it ranks highly in instrument usage for the assessment of executive 
functioning, but it is unclear why so few of the included studies used this instrument. 
Speculatively, it may be because the Wisconsin Card Sorting Test measures the same 
constructs, the availability of the instrument or some other convenience factor, but it would 
be beneficial to investigate how the scores of these measures compare in substance 
dependence populations. The Behaviour Rating Inventory of Executive Function Adult 
(BRIEF-A) is also ranked among the top ten in the practice report but used in only nine of 
the included studies. The BRIEF-A is a specialised questionnaire in both a self-report and 
an informant report format. This is significant because it addresses the possible limitation 
of reporting bias observed in substance dependent populations and identifies different 
manifestations of executive dysfunction, especially pertaining to activities of daily living 
(which standard instruments do not measure). Finally, when intelligence and achievement 
instruments are accounted for, the current findings and the reported neuropsychological 
assessment practices correspond; the Wechsler Adult Intelligence Scale (various versions) 
is the most used of these instruments. Overall, these findings suggest that future studies on 
the relationship between substance dependence and executive functioning would do well to 
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more carefully consider the merits and demerits of available instruments such as the 
Halstead Category Test and to avoid choosing instruments on the basis of convenience. 
5.2.4 Substance Use and Dependence Assessment Criteria 
More than half of the studies used the substance use and dependence criteria from 
the various versions of the Diagnostic and Statistical Manual of Mental Disorders. In 
comparison only a small percentage (6.7%) of the studies used the criteria from the 
International Statistical Classification of Diseases and Related Health Problems. 
Furthermore, another 34 different measures were used to establish substance use and 
dependence. Even though the criteria are similar, there are nonetheless differences, such as 
omitting specific criteria and thereby having broader inclusion criteria. This, in turn, 
increases the heterogeneity of the combined samples of the included studies. 
5.2.5 Study Characteristics 
5.2.5.1 Theories and Descriptions of Executive Functioning. 
Although a broad understanding of executive functioning exists, being a higher 
order or supervisory mental process, there is still no agreement about the constituent 
functions or lower order mental processes that make up this broad construct (Goldberg, 
2017; Goldstein et al., 2014; Suchy et al., 2017). This was also evident when the constructs 
used to define executive functioning in the included research studies were extracted. The 
variability is high, as thirty-six different constructs were used to define executive 
functioning and the number of constructs used per study ranged between one and ten. This 
also indicates that the construct validity of executive functioning for the various studies 
may be low. This is of great concern as the neuropsychological instrument selection and 
subsequent results depend on the theoretical framework of executive functioning. As 
conceptualised by Suchy, Niermeyer and Ziemnik (2017), the possible theoretical 
frameworks for executive functioning can be classified into clinical models, cognitive 
models or developmental models; furthermore, the executive functioning measures can be 
categorised as clinical, experimental or self-report. Taking this into consideration, it is 
evident that it is essential to explicitly report the theoretical models used for research 
purposes. Yet, only 36 per cent of the included studies provided a description or definition 
of executive functioning. Furthermore, this fragmentation raises the question of whether it 
is valid to regard the studies as measuring the same neuropsychological construct. 
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5.2.5.2 Study Designs. 
Three quarters of all the included studies had a cross-sectional design. Although 
cross-sectional designs can be easier to conduct than longitudinal designs, the main 
limitation for this study design is that causal inferences cannot be established. As already 
emphasised, in the fields of substance dependence and addiction there are numerous 
confounding variables which already lowers the confidence in both causality itself and the 
direction of causality in substance dependence and executive functioning. Therefore, 
longitudinal studies are of utmost importance and it is disappointing that so few have been 
conducted. 
There were very few studies with a retrospective cohort design and only a select 
number of substances have been investigated in this way. A retrospective cohort design is 
important when investigating historical factors in substance dependent populations, for 
example age of onset, differences in use, differences in severity and other premorbid 
factors. However, this study design may be limited by the possibility of inaccurate medical 
history, especially when this is reliant on self-report data. 
Where the studies with a retrospective cohort design obtain and analyse historical 
data leading up to a certain point in time, the studies with a prospective cohort design 
measure changes over time and report on a number of different outcomes. Specifically, if 
executive functioning scores predicted treatment outcomes, the likelihood of drop-out, 
successful abstinence, relapse, neurophysiological or biological changes, the likelihood of 
polysubstance use, the development of substance disorders and severity of use. Other 
studies reported if executive functioning scores improved with either abstinence or other 
variables such as social support. In brief, the investigated outcomes were found to be 
highly diverse for the studies using a prospective cohort design. The main limitation noted 
for both retrospective and prospective cohort design was the limited control of certain 
variables, for example the substance use or abstinence over the course of the research 
project, the accuracy of self-report data and the attrition rate. 
The few studies with randomised and non-randomised controlled trials had diverse 
pharmacological and rehabilitation treatment interventions. Because of these diverse 
interventions the results from these studies cannot be combined and do not necessarily 
report specifically on the relationship between executive functioning scores and substance 
dependence. Nevertheless, combined with studies using a prospective cohort design, there 
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were noteworthy observations, especially related to methadone treatment. Some of these 
studies reported higher executive function scores with methadone treatment and others 
reported lower executive function scores. There were also a number of controlled trials 
investigating the effects of different cognitive training regiments on executive functioning 
with some promising findings.  
Interestingly, there were only two case studies, and both of these were for cannabis 
(Crean, et al., 2011; Gonçalves et al., 2010). These studies provided expert opinions and 
specifics related to the patient history that are not necessarily evident in other research 
designs. This demonstrates that case studies may be valuable by providing substance-
specific information as well as possible in-depth exploration of confounding variables. 
In terms of the comparators used in the research studies, the majority of the studies 
used a healthy control group as a comparator. All the randomised and non-randomised 
control trials had groups receiving a controlled or placebo intervention. There were also a 
number of studies comparing groups that differ in the type of substance, the method of use, 
the dosage, or exposure history. Comparator groups may be an alternative for the lack of 
neuropsychological normative data for certain populations, possibly controlling for many 
other confounding variables not controlled for in normative data. 
5.2.5.3 Settings. 
The results for the various settings of the research studies show that the samples 
were drawn from both the community and various types of treatment facilities. There were 
also studies with samples comprising of individuals from community and different types of 
treatment facilities. This is noteworthy because individuals from different settings differ 
considerably in terms of a number of factors, including current substance use status, 
abstinence, withdrawal status and pharmacological treatment. For example, individuals 
from a treatment setting may be in a withdrawal state and receive psychotropic treatment, 
whereas individuals from a community setting may be under the influence of a substance 
at the time of testing. As discussed in Chapter 1, this variability in the patterns of 
substance use and treatment has been highlighted in previous systematic reviews (Cohen et 
al., 2017; Crean, Tapert, et al., 2011; Potvin et al., 2018; Stevens et al., 2014) and can be 
regarded as a significant confounding factor. 
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5.2.5.4 Countries. 
Of all the included studies, 46 per cent originated from North America, 32 per cent 
originated from Europe and 12 per cent from Asia. Less than five per cent of the studies 
were conducted in Oceania, Latin America and the Caribbean. The most conspicuous is 
that there were no studies from any African country. This geographical bias mirrors that 
found in much scientific research and is a significant concern with regard to the 
international applicability of findings. 
5.2.5.5 Risk of Bias. 
As discussed in Chapter 4, the risk of bias for the studies may have been 
overestimated as many of the judgements could be regarded as limitations rather than 
introduced bias. A third of the studies were judged as having a high risk of bias for 
confounders and contamination. The reason for these judgements is because the status of 
substance use, abstinence, withdrawal or psychotropic treatment was questionable and, in 
many studies, not reported at all. However, it is difficult and, in some cases, impossible to 
control these factors and therefore it may be regarded as a limitation. Although omitted 
information was not judged as a risk of bias, it remains of great concern, especially when 
considering that six studies had no information about the ages of the samples, 46 studies 
did not report the education level, 23 studies did not report the gender proportions of the 
samples, 24 studies did not report the criteria used to determine substance use or 
dependence, and 21 studies did not report the settings where samples were recruited from. 
5.2.6 Executive Functioning and Substance Dependence Findings 
The included research studies are highly heterogenous and therefore a meta-
analytic synthesis of the extracted data for the results would not be valid. This was 
anticipated in the protocol and subsequently confirmed when study selection was 
completed. Therefore, it was clear a narrative synthesis was required for the results; 
however, to conduct a narrative synthesis it is also required for the results of the individual 
research studies to be combined to present the overall findings. This was done in three 
ways. First, the main results related to executive functioning scores and substance 
disorders or dependence were located, synthesised and these combined findings were 
reported. This provided an overview of the combined results for all 390 of the included 
research studies. Second, these findings were then cross-tabulated with the various 
substances to provide an overview of the combined results for the respective substances 
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that were investigated. Finally, the findings were cross-tabulated with the different study 
designs to give an overview of the combined results for the study designs.  
As already outlined in this chapter, it is important to consider the caveats in both 
the demographics of the population samples and the various components of the studies 
when interpreting the synthesised results. In section 5.4.8, I provide recommendations to 
address these limitations. Nonetheless, these synthesised results provide a general 
overview, indicate possible gaps and can be used to guide future research. 
Two thirds of the studies reported a relationship between lower executive 
functioning scores and substance dependence. Although this is a large proportion, the 
number of studies reporting mixed, inconclusive and no relationship remain substantial. 
The three studies reporting higher executive functioning scores with substance dependence 
are controversial, but may be important. Even though certain confounders may have had an 
impact on these results, the reported findings are curious. For instance, one of the included 
studies (Coulston, et al., 2007) reported that a schizophrenia group with lifetime cannabis 
abuse/dependence demonstrated better performance predominantly in the domains of 
attention, processing speed and executive functions in comparison to a schizophrenia 
group without this lifetime abuse/dependence. This was further associated with the 
frequency and recency of cannabis use. Although there are a number of other studies in 
this review that conversely reported lower executive function scores in schizophrenia 
populations, the quality and transparency of this particular study prompted further inquiry. 
With scoping searches (González-Pinto et al., 2016; Hanna et al., 2016; Jockers-Scherübl 
et al., 2007; Moustafa et al., 2016) it was confirmed that the cannabis-cognition-psychosis 
relationship may not fit in with the conventional brain-disease model or 
neurodevelopmental model of addiction. Clearly, this is an area of investigation that needs 
to be pursued further. 
It can therefore be surmised from these synthesised findings that the existing body of 
research for executive functioning in substance dependence does not provide exhaustive 
evidence and a number of gaps have been identified. Before these gaps and 
recommendations for future research are discussed in section 5.4, the strengths and 
limitations of the systematic review should be considered. 
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5.3 Strengths and Limitations of the Systematic Review 
A crucial requirement for any systematic review is the adherence to the predefined 
protocol (see Appendix A). The protocol guided the research project and every effort was 
made to follow the predefined criteria. However, certain deviations were necessary. A 
number of terms and word stems listed in the protocol resulted in an unmanageably large 
number of search results. For this reason, the search strategy was refined to ensure 
specificity (where relevant evidence is identified) and sensitivity (where irrelevant 
evidence is minimised). In conjunction, the list of databases in the protocol was also 
refined to ensure specificity and sensitivity. Even with a refined search strategy, the final 
number of search results was higher than anticipated (n=16 265) and cross-referencing the 
individual results with results from previous systematic reviews was not practical. 
Nonetheless, the search strategy did include citation chaining of previous systematic 
reviews with additional snowball citation chaining (see section 3.3.3). 
Population inclusion criteria was formulated in the protocol to include human 
populations; diagnosed with substance dependence; or diagnosed with substance use 
disorder; or no diagnosis with recurrent use of psychoactive substances. The latter, 
however, was found to be too ambiguous when piloting the screening and was removed as 
an inclusion criterion. This ensured all included studies had samples with a reported 
diagnosis of addiction, substance-use disorder or substance dependence. All other 
inclusion and exclusion criteria were used exactly as defined in the protocol by both 
reviewers. Differences and consensus were not reported to the supervisor to monitor bias. 
This was because the agreement between the two reviewers was higher than the stipulated 
statistical requirements. Screening and selection of titles/abstracts and full-text articles 
were done in duplicate; however, the second reviewer screened and selected a sample of 
the studies and not all of the studies as proposed. This is an acceptable standard for 
conducting systematic reviews if the agreement between reviewers is high and in this case 
the agreement was higher than the required kappa score of 0.8 for both the titles/abstracts 
and the full-texts. 
As discussed in Chapter 3, there were a number of full-text articles not available for 
screening despite efforts of requesting these articles from the university library and 
contacting the authors directly. Furthermore, a few articles were not available in English. It 
was proposed that these articles would be submitted to Cochrane Task Exchange for 
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translation; however, this was not feasible in terms of the timeframes and the English 
versions were requested from the authors directly. These included titles and abstracts with 
unavailable full-text articles are publicly available at DOI: 10.13140/RG.2.2.14658.32962. 
The protocol specified that Covidence would also be used for data extraction but 
because the software module was not as customisable as anticipated it was decided to use 
Google Forms instead. This meant that the extracted data were not highlighted in the 
specific article PDF documents as proposed in the protocol. Furthermore, each reviewer 
extracted data for a proportion of the studies and, therefore, data extraction was not done in 
duplicate. All other criteria for data extraction were followed as proposed. 
Quality assessment was not carried out after data extraction because it was 
established during the course of the review that the reviewer is most familiar with each 
individual study directly after data extraction and, therefore, better able to make 
appropriate judgements, as opposed to a separate process of screening each article and then 
making judgements. Because of the customisability issues of Covidence, the quality 
assessment was also conducted on Google Forms. All other criteria for quality assessment 
were followed as proposed. The analysis of the extracted data was carried out exactly as 
described in the protocol.  
The main limitations of the current systematic review are therefore: (1) The 
deviations from the predefined protocol which may have introduced bias; (2) Data 
extraction was not executed in duplicate which may have introduced bias; (3) The risk of 
bias for the individual studies may have been overestimated; (4) There were a number of 
full-text articles that could not be obtained for screening. The strengths of the systematic 
review are as follows: (1) A comprehensive, transparent and rigorous search strategy; (2) 
The use of both electronic databases and citation chaining for searches; (3) Blinded 
screening and selection which minimised bias; (4) The availability of comprehensive and 
detailed data for the use in subsequent research. 
5.4 Identified Gaps and Implications for Future Research 
A heuristic of the synthesised components of the available 390 empirical studies 
reveals a middle-aged individual of the male gender, who completed secondary education 
(partially or in full) and is a citizen of the United States of America. He is diagnosed with 
substance dependence or substance-use disorder for either alcohol, cocaine or cannabis 
using the DSM-IV criteria and is currently receiving pharmacological and/or rehabilitative 
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treatment. His executive functioning is assessed on a single occasion, using the Wisconsin 
Card Sorting Test, the Stroop Test, and/or the Trail-Making Test. The assessment results 
indicate that he has lower executive functioning scores in comparison to healthy 
individuals without substance dependence and who have the same demographics as him. 
This heuristic view of the results clearly demonstrates the considerable restrictions of the 
existing body of knowledge for the neuropsychology of executive functioning and 
substance dependence.  
5.4.1 Demographics 
There is a lack of empirical studies that investigate the effects of substance 
dependence on executive functioning in both adolescent and senior-adult populations. This 
lack of research for both of these age groups is significant, especially when considering the 
well-known vulnerability of the developing adolescent brain (Arain et al., 2013; Griffin, 
2017) and the prevalence of neurodegenerative diseases among senior populations, 
globally (Béjot & Yaffe, 2019; Hou et al., 2019; Johnson, 2015).  
Future research studies need to include more female participants. This is supported 
by the World Drug Report 2019 (United Nations Office on Drugs and Crime, 2019) which 
explains that substance-use research, in general, has predominantly used male participants; 
and consequently resulted in male-oriented substance-use interventions. Furthermore, the 
critical need to develop effective treatments tailored to the specific needs of women has 
been emphasised by world leading organisations (Arpa, 2017; National Institute on Drug 
Abuse, 2018) and to do this, any research pertaining to substance-use needs to include 
more female participants. 
Education has a pervasive and potent effect on neuropsychological assessment 
performance (Lezak et al., 2012). In line with this, cross-tabulation of the educational 
years and the findings of the combined studies revealed that the samples that had less than 
secondary education had lower executive functioning scores in comparison to the samples 
who had some secondary education, and even lower than the samples with full secondary 
education or more. However, only a small number of studies had samples with less than 
nine years of education and, therefore, the specific relationship between educational level 
and executive functioning performance in substance dependent populations remains 
unclear. If a lower educational level is associated with lower executive functioning it may 
be considered an aggravating factor in substance dependence and more research is 
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therefore crucial. This is further supported by the fact that, globally, one in five people are 
excluded from education (UNESCO Institute of Statistics, 2018). 
5.4.2 Substances 
Very little research is available that investigates the relationship between executive 
functioning and dependence to ketamine, amphetamine and benzodiazepine. 
The very small number of research studies with ketamine dependent samples is 
particularly alarming because epidemiological research indicates that prevalence has 
increased in many countries (McCambridge, Winstock et al., 2006; World Health 
Organization, 2012). Furthermore, none of these studies investigated the relationship 
between ketamine dependence and executive functioning longitudinally; nonetheless, 
ketamine is now being used internationally as a novel treatment for depression (Bratsos & 
Saleh, 2019; Grady et al., 2017; Strong & Kabbaj, 2018). In the 1990s, specific 
pharmacological treatment was introduced for pain management and reported as being 
safe. This was done without sufficient research for the associated risks (including the 
progressive addictive risk of the treatment) and resulted in a catastrophic epidemic, today 
known as the opioid crisis (DeWeerdt, 2019; Van Zee, 2009).  
Benzodiazepine is another prescription drug with potential long-term risks. This 
sedative may be associated with neurofunctional impairments and its potential to increase 
the risk of developing neurodegenerative diseases is being researched extensively (Brandt 
& Leong, 2017; De Gage et al., 2014; Richardson et al., 2019). Contrary to the latter, the 
effects of benzodiazepine dependence on executive functioning has not received much 
attention. Likewise, the lack of studies for amphetamines and prescription stimulants are 
also of great concern, especially when considering the global statistics of 29 million users, 
which is equivalent to the number of opiate users (United Nations Office on Drugs and 
Crime, 2019). Opioids are considered to result in the greatest harm to the health of 
individuals and accounted for 66 per cent of deaths due to drug-related disorders. Fifty-
three million people use opioids (opiates and prescription opioids) globally. Yet, this is 
also a substance with little research pertaining to dependence and executive functioning.  
Finally, the most commonly used illegal drug, as well as the primary drug of concern 
for people in treatment, is cannabis (United Nations Office on Drugs and Crime, 2017, 
2019). Almost 4 per cent of the global population or 188 million people use cannabis. 
Furthermore, cannabis is the primary drug of concern for between 29 and 56 per cent of 
 
  95 
the global population in treatment. This is significantly higher (globally ranging between 
43 and 83 per cent) in persons younger than 20 years of age (Siphokazi et al., 2018; United 
Nations Office on Drugs and Crime, 2019). These statistics are critical, especially the 
extreme prevalence in adolescent populations who are most vulnerable in terms of 
neurodevelopment. Greater emphasis needs to be placed on investigating the relationship 
between cannabis dependence and executive functioning. 
5.4.3 Assessment Measures 
In terms of neuropsychological assessment instruments, more research is required 
for particular neuropsychological instruments that assess the executive functioning in 
substance dependence populations, specifically (1) the Delis-Kaplan Executive Function 
System, (2) the Behavior Rating Inventory of Executive Function, and (3) the Halstead 
Category Test. In addition to the primary objective of more research to establish the 
relationship between executive functioning and substance dependence, more studies are 
also required to investigate the validity and reliability of these instruments. As discussed in 
Chapter 2, future research should also place an emphasis on cultural-sensitivity with 
neuropsychological assessment and ensure assessment is adapted for non-Western cultures 
(Ardila, 2005; Greenfield, 1997; Rosselli & Ardila, 2003). 
5.4.4 Study Designs 
It is of major concern that the overwhelming majority of studies were cross-
sectional in nature. Overall, additional longitudinal studies are required, but considering 
the diverse outcomes of the existing prospective cohort designs, more longitudinal studies 
are required in particular that investigate executive functioning and (1) treatment 
outcomes; (2) the likelihood of treatment drop-out; (3) success rate of abstinence; (4) 
likelihood of relapse; (5) neurophysiological or biological changes; (6) likelihood of 
polysubstance use; (7) the development of substance disorders; (8) and the severity of use. 
Furthermore, there is a lack of longitudinal studies investigating whether executive 
functioning scores improve with abstinence for the various substances. Of importance, and 
in conjunction with the relatively small number of studies for the adolescent group already 
mentioned, is the lack of longitudinal studies investigating the effect of early-onset 
substance dependence on executive functioning. As presented in the literature review, 
research emphasises the vulnerability of the developing adolescent brain, especially the 
prefrontal cortex which is directly associated with executive functioning (Arain et al., 
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2013; Griffin, 2017). This has potentially significant implications for substance 
dependence and addiction. 
While it makes intuitive sense that there is a relationship between executive 
functioning and substance dependence, this has very seldom been tested in controlled 
trials. From the systematic review it would appear that the relationship is much less 
commonly detected in such trials than in correlational studies, casting further doubt on the 
robustness of the relationship. In terms of studies that researched treatment, the findings in 
the various controlled trials that investigated the effects of methadone maintenance on 
executive functioning are conflicting and more research is required to establish consensus. 
Moreover, the few studies that investigated the effects of cognitive training on executive 
functioning for the treatment of substance dependence had promising findings which also 
supports the need for more research. 
5.4.5 Settings 
Future empirical studies need to control for the settings of participant recruitment 
more stringently. The diversity in settings is a significant confounding variable in terms of 
substance use behaviours and other factors (for example, the effects of treatment or 
withdrawal). Furthermore, the majority of studies recruited participants from treatment 
settings. This is not representative of the global population, as only one in seven people 
with substance dependence receive treatment (United Nations Office on Drugs and Crime, 
2019). The effects of substance dependence on executive in populations from other 
settings may differ in populations from treatment settings. 
5.4.6 Countries 
The significant lack of research in certain global regions is concerning, especially 
when epidemiological statistics from the United Nations Office on Drugs and Crime 
(2017) are considered. Although substance dependence prevalence is not presented 
specifically in the latter report, it can be inferred from both the data about population 
numbers in treatment and drug-related deaths, that all global regions are detrimentally 
affected by substance dependence. To clarify, the majority of research included in this 
systematic review originates from North America and the estimated number of drug-
related deaths for this region, as reported in 2015, is almost 60 000. In comparison, almost 
70 000 drug-related deaths are reported for Asia and more than 40 000 for Africa. These 
statistics exacerbate the possible impact of the critical lack of research for Asia and non-
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existent research for Africa. The latter may be, at least in part, attributed to the 
internationally recognised need for culturally-adapted neuropsychological assessment 
(Arango-Lasprilla et al., 2016; Bender et al., 2010; Rivera Mindt et al., 2010; Sue & 
Chang, 2003; Watts & Shuttleworth-Edwards, 2016). Furthermore, when cultural 
sensitivity is considered (as discussed in Chapter 2) it is not valid, nor ethical, to use the 
findings from research conducted in one culture to make inferences about another culture 
(Lezak et al., 2012). Therefore, based on the results of this systematic review, the 
relationship between executive functioning and substance dependence for populations in 
these regions remain unknown. Neuropsychological assessment instruments need to be 
culturally-adapted and normative data collected for research to be conducted in non-
Western global regions. 
5.4.7 Executive Functioning and Substance Dependence Findings  
Although the synthesis of findings confirmed lower executive functioning 
performance scores are commonly observed in substance dependence, studies need to be 
replicated to identify the specific impact of confounders as well as investigate the reasons 
for outlier empirical studies. For example, the higher executive functioning scores reported 
with cannabis dependence in schizophrenia populations. In addition, these findings are 
primarily from cross-sectional studies and longitudinal studies could provide a better 
understanding of the relationship between executive functioning and substance 
dependence. Particularly where these longitudinal studies investigate, for example, 
premorbid functioning, disease progression and abstinence. 
5.4.8 Current Systematic Review as Basis for Future Research 
The included studies of this systematic review can be used to conduct a number of 
different meta-analytic systematic reviews. This can be done according to specific 
substances and/or specific study designs. The lower heterogeneity and synthesis of 
statistical power would provide high quality evidence. Similarly, the lack of research for 
gender differences can possibly be addressed by using refined inclusion criteria and 
conducting the appropriate meta-analyses. Furthermore, the data from the included studies 
can be used for comparative analyses of the scores from any combination of the 
neuropsychological assessment instruments. For example, how The Wisconsin Card 
Sorting Test and Halstead Category Test scores compare as instruments measuring the 
same constructs; or how the scores of the Behavior Rating Inventory of Executive 
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Function, and other instruments sensitive to the activities of daily living, compare with 
standard neuropsychological instruments. 
Finally, the myriad of constructs used to describe executive functioning confirm 
the persistent lack of consensus. It is important to advance the field by increasing our 
understanding of executive functioning. This may be addressed by conducting factor 
analytical research. In addition, and as shown in the current systematic review, it may be 
possible to establish the various constructs used in multiple studies and then, using the 
combined data from these studies, conduct the appropriate factor analyses. Essentially, this 
will entail combining systematic review and factor analytical methodologies. 
5.5 Conclusions 
The synthesis of the existing empirical studies related to executive functions and 
substance dependence confirmed that a relationship exists between these two constructs as 
is predicted by theoretical models of addiction. However, the synthesis of the various 
components of these studies revealed a number of critical gaps in the available research. 
This is most apparent in the discovery that the current body of knowledge is restricted in 
terms of the population it represents, especially with regard to gender, age, education and 
nationality; as well as the limited number of longitudinal studies and studies for specific 
substances of dependence known to be of epidemic proportions. The extent of 
fragmentation of executive functioning as a theoretical construct was revealed as another 
concern, and this fragmentation is further amplified by the multitude and diverse 
combinations of neuropsychological assessment instruments that were used to assess 
executive functioning. Based on these identified gaps, a number of recommendations were 
made, including the need for additional replication studies, meta-analytical systematic 
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